0000918541 12/31 2021 Q1 false 0000918541 2021-01-01 2021-03-31 xbrli:shares 0000918541 2021-05-03 iso4217:USD 0000918541 2020-01-01 2020-03-31 iso4217:USD xbrli:shares 0000918541 2021-03-31 0000918541 2020-12-31 0000918541 us-gaap:SeriesDPreferredStockMember 2021-03-31 0000918541 us-gaap:SeriesDPreferredStockMember 2020-12-31 0000918541 us-gaap:SeriesBPreferredStockMember 2020-12-31 0000918541 us-gaap:SeriesBPreferredStockMember 2021-03-31 0000918541 us-gaap:CommonStockMember 2020-12-31 0000918541 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0000918541 us-gaap:RetainedEarningsMember 2020-12-31 0000918541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0000918541 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0000918541 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0000918541 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0000918541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0000918541 us-gaap:CommonStockMember 2021-03-31 0000918541 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0000918541 us-gaap:RetainedEarningsMember 2021-03-31 0000918541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0000918541 us-gaap:CommonStockMember 2019-12-31 0000918541 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0000918541 us-gaap:WarrantMember 2019-12-31 0000918541 us-gaap:RetainedEarningsMember 2019-12-31 0000918541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-12-31 0000918541 2019-12-31 0000918541 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0000918541 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0000918541 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0000918541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-01-01 2020-03-31 0000918541 us-gaap:CommonStockMember 2020-03-31 0000918541 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0000918541 us-gaap:WarrantMember 2020-03-31 0000918541 us-gaap:RetainedEarningsMember 2020-03-31 0000918541 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0000918541 2020-03-31 0000918541 nnbr:LifeSciencesMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2020-10-31 0000918541 nnbr:LifeSciencesMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2020-10-01 2020-10-31 0000918541 nnbr:LifeSciencesMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2021-03-31 0000918541 nnbr:LifeSciencesMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2020-12-31 0000918541 nnbr:LifeSciencesMember us-gaap:DiscontinuedOperationsDisposedOfBySaleMember 2020-01-01 2020-03-31 0000918541 nnbr:LifeSciencesMember 2020-01-01 2020-03-31 0000918541 2020-10-06 2020-10-06 nnbr:segment 0000918541 us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 nnbr:CorporateAndEliminationsMember 2021-01-01 2021-03-31 0000918541 us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 nnbr:CorporateAndEliminationsMember 2020-01-01 2020-03-31 xbrli:pure 0000918541 us-gaap:CustomerConcentrationRiskMember nnbr:MajorCustomerMember us-gaap:AccountsReceivableMember 2021-01-01 2021-03-31 0000918541 us-gaap:CustomerConcentrationRiskMember nnbr:MajorCustomerMember us-gaap:AccountsReceivableMember 2020-01-01 2020-12-31 0000918541 nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 nnbr:MobileSolutionsMember 2020-12-31 0000918541 nnbr:PowerSolutionsMember 2020-12-31 0000918541 nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 nnbr:MobileSolutionsMember 2021-03-31 0000918541 nnbr:PowerSolutionsMember 2021-03-31 0000918541 nnbr:WuxiWeifuAutocamPrecisionMachineryCompanyLtdMember 2021-03-31 0000918541 us-gaap:CorporateJointVentureMember 2020-12-31 0000918541 us-gaap:CorporateJointVentureMember 2021-01-01 2021-03-31 0000918541 us-gaap:CorporateJointVentureMember 2021-03-31 0000918541 nnbr:TermLoanFacilityMember 2021-03-22 0000918541 nnbr:AssetBackedCreditFacilityMember 2021-03-22 0000918541 nnbr:TermLoanFacilityMember 2021-03-31 0000918541 nnbr:TermLoanFacilityMember 2020-12-31 0000918541 nnbr:SeniorSecuredTermLoanBMember 2021-03-31 0000918541 nnbr:SeniorSecuredTermLoanBMember 2020-12-31 0000918541 nnbr:IncrementalTermLoanMember 2021-03-31 0000918541 nnbr:IncrementalTermLoanMember 2020-12-31 0000918541 us-gaap:ForeignLineOfCreditMember 2021-03-31 0000918541 us-gaap:ForeignLineOfCreditMember 2020-12-31 0000918541 srt:MinimumMember nnbr:TermLoanFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-03-22 2021-03-22 0000918541 nnbr:TermLoanFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-03-22 2021-03-22 0000918541 nnbr:TermLoanFacilityMember nnbr:VariousBenchmarkRatesMember 2021-03-22 2021-03-22 0000918541 nnbr:TermLoanFacilityMember 2021-01-01 2021-03-31 0000918541 us-gaap:LetterOfCreditMember 2021-03-22 0000918541 us-gaap:BridgeLoanMember 2021-03-22 0000918541 nnbr:AssetBackedCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-03-31 0000918541 srt:MaximumMember nnbr:AssetBackedCreditFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-03-22 2021-03-22 0000918541 nnbr:FederalFundsOrPrimeRateMember srt:MinimumMember nnbr:AssetBackedCreditFacilityMember 2021-03-22 2021-03-22 0000918541 srt:MaximumMember nnbr:FederalFundsOrPrimeRateMember nnbr:AssetBackedCreditFacilityMember 2021-03-22 2021-03-22 0000918541 nnbr:AssetBackedCreditFacilityMember 2021-01-01 2021-03-31 0000918541 us-gaap:LetterOfCreditMember 2021-01-01 2021-03-31 0000918541 nnbr:AssetBackedCreditFacilityMember 2021-03-31 0000918541 nnbr:SeniorSecuredTermLoanBMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-03-31 0000918541 nnbr:SeniorSecuredTermLoanBMember 2021-01-01 2021-03-31 0000918541 nnbr:IncrementalTermLoanMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-03-31 0000918541 nnbr:IncrementalTermLoanMember 2021-01-01 2021-03-31 0000918541 nnbr:SeniorSecuredRevolvingFacilityMember us-gaap:LondonInterbankOfferedRateLIBORMember 2021-01-01 2021-03-31 0000918541 us-gaap:PrimeRateMember nnbr:SeniorSecuredRevolvingFacilityMember 2021-01-01 2021-03-31 0000918541 nnbr:SeniorSecuredRevolvingFacilityMember 2021-01-01 2021-03-31 0000918541 us-gaap:InterestRateSwapMember 2021-03-22 2021-03-22 0000918541 2020-03-01 2020-03-31 0000918541 srt:MaximumMember 2021-03-31 0000918541 2019-11-01 2019-11-01 0000918541 us-gaap:PrivatePlacementMember us-gaap:SeriesDPreferredStockMember 2021-03-22 2021-03-22 0000918541 us-gaap:PrivatePlacementMember us-gaap:SeriesDPreferredStockMember 2021-03-22 0000918541 us-gaap:SeriesDPreferredStockMember 2021-03-22 0000918541 us-gaap:SeriesDPreferredStockMember 2021-03-22 2021-03-22 0000918541 srt:ScenarioForecastMember us-gaap:SeriesDPreferredStockMember 2026-03-22 2026-03-22 0000918541 us-gaap:SeriesDPreferredStockMember 2021-01-01 2021-03-31 0000918541 us-gaap:SeriesBPreferredStockMember 2021-01-01 2021-03-31 0000918541 us-gaap:SeriesCPreferredStockMember us-gaap:CommonStockMember 2020-04-15 0000918541 country:US us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 country:US us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 country:US us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000918541 country:US 2021-01-01 2021-03-31 0000918541 country:CN us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 country:CN us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 country:CN us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000918541 country:CN 2021-01-01 2021-03-31 0000918541 country:BR us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 country:BR us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 country:BR us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000918541 country:BR 2021-01-01 2021-03-31 0000918541 country:MX us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 country:MX us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 country:MX us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000918541 country:MX 2021-01-01 2021-03-31 0000918541 country:DE us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 country:DE us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 us-gaap:IntersegmentEliminationMember country:DE 2021-01-01 2021-03-31 0000918541 country:DE 2021-01-01 2021-03-31 0000918541 us-gaap:OperatingSegmentsMember country:PL nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 us-gaap:OperatingSegmentsMember country:PL nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 us-gaap:IntersegmentEliminationMember country:PL 2021-01-01 2021-03-31 0000918541 country:PL 2021-01-01 2021-03-31 0000918541 nnbr:OtherCountryMember us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 nnbr:OtherCountryMember us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 nnbr:OtherCountryMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000918541 nnbr:OtherCountryMember 2021-01-01 2021-03-31 0000918541 us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000918541 country:US us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 country:US us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 country:US us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0000918541 country:US 2020-01-01 2020-03-31 0000918541 country:CN us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 country:CN us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 country:CN us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0000918541 country:CN 2020-01-01 2020-03-31 0000918541 country:BR us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 country:BR us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 country:BR us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0000918541 country:BR 2020-01-01 2020-03-31 0000918541 country:MX us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 country:MX us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 country:MX us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0000918541 country:MX 2020-01-01 2020-03-31 0000918541 country:DE us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 country:DE us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 us-gaap:IntersegmentEliminationMember country:DE 2020-01-01 2020-03-31 0000918541 country:DE 2020-01-01 2020-03-31 0000918541 us-gaap:OperatingSegmentsMember country:PL nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 us-gaap:OperatingSegmentsMember country:PL nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 us-gaap:IntersegmentEliminationMember country:PL 2020-01-01 2020-03-31 0000918541 country:PL 2020-01-01 2020-03-31 0000918541 nnbr:OtherCountryMember us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 nnbr:OtherCountryMember us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 nnbr:OtherCountryMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0000918541 nnbr:OtherCountryMember 2020-01-01 2020-03-31 0000918541 us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0000918541 nnbr:AutomotiveMember us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 nnbr:AutomotiveMember us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 us-gaap:IntersegmentEliminationMember nnbr:AutomotiveMember 2021-01-01 2021-03-31 0000918541 nnbr:AutomotiveMember 2021-01-01 2021-03-31 0000918541 nnbr:GeneralIndustrialMember us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 nnbr:GeneralIndustrialMember us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 us-gaap:IntersegmentEliminationMember nnbr:GeneralIndustrialMember 2021-01-01 2021-03-31 0000918541 nnbr:GeneralIndustrialMember 2021-01-01 2021-03-31 0000918541 nnbr:ElectricalMember us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 nnbr:ElectricalMember us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 us-gaap:IntersegmentEliminationMember nnbr:ElectricalMember 2021-01-01 2021-03-31 0000918541 nnbr:ElectricalMember 2021-01-01 2021-03-31 0000918541 nnbr:OtherSubsegmentMember us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2021-01-01 2021-03-31 0000918541 nnbr:OtherSubsegmentMember us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2021-01-01 2021-03-31 0000918541 nnbr:OtherSubsegmentMember us-gaap:IntersegmentEliminationMember 2021-01-01 2021-03-31 0000918541 nnbr:OtherSubsegmentMember 2021-01-01 2021-03-31 0000918541 nnbr:AutomotiveMember us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 nnbr:AutomotiveMember us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 us-gaap:IntersegmentEliminationMember nnbr:AutomotiveMember 2020-01-01 2020-03-31 0000918541 nnbr:AutomotiveMember 2020-01-01 2020-03-31 0000918541 nnbr:GeneralIndustrialMember us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 nnbr:GeneralIndustrialMember us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 us-gaap:IntersegmentEliminationMember nnbr:GeneralIndustrialMember 2020-01-01 2020-03-31 0000918541 nnbr:GeneralIndustrialMember 2020-01-01 2020-03-31 0000918541 nnbr:ElectricalMember us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 nnbr:ElectricalMember us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 us-gaap:IntersegmentEliminationMember nnbr:ElectricalMember 2020-01-01 2020-03-31 0000918541 nnbr:ElectricalMember 2020-01-01 2020-03-31 0000918541 nnbr:OtherSubsegmentMember us-gaap:OperatingSegmentsMember nnbr:MobileSolutionsMember 2020-01-01 2020-03-31 0000918541 nnbr:OtherSubsegmentMember us-gaap:OperatingSegmentsMember nnbr:PowerSolutionsMember 2020-01-01 2020-03-31 0000918541 nnbr:OtherSubsegmentMember us-gaap:IntersegmentEliminationMember 2020-01-01 2020-03-31 0000918541 nnbr:OtherSubsegmentMember 2020-01-01 2020-03-31 0000918541 nnbr:MajorCustomerMember 2021-01-01 2021-03-31 0000918541 us-gaap:CustomerConcentrationRiskMember nnbr:MajorCustomerMember us-gaap:RevenueFromContractWithCustomerMember 2021-01-01 2021-03-31 0000918541 nnbr:MajorCustomerMember 2020-01-01 2020-03-31 0000918541 us-gaap:CustomerConcentrationRiskMember nnbr:MajorCustomerMember us-gaap:RevenueFromContractWithCustomerMember 2020-01-01 2020-03-31 0000918541 us-gaap:SegmentDiscontinuedOperationsMember 2020-01-01 2020-03-31 0000918541 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0000918541 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000918541 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0000918541 us-gaap:RestrictedStockMember 2020-01-01 2020-03-31 0000918541 us-gaap:PerformanceSharesMember 2021-01-01 2021-03-31 0000918541 us-gaap:PerformanceSharesMember 2020-01-01 2020-03-31 0000918541 nnbr:EmployeesMember us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0000918541 us-gaap:RestrictedStockMember nnbr:NonExecutiveDirectorsMember 2021-01-01 2021-03-31 0000918541 us-gaap:RestrictedStockMember 2021-03-31 0000918541 us-gaap:RestrictedStockMember 2020-12-31 0000918541 nnbr:PerformanceSharesTsrAwardsMember 2021-01-01 2021-03-31 0000918541 nnbr:PerformanceSharesReturnOnInvestedCapitalMember 2021-01-01 2021-03-31 0000918541 nnbr:PerformanceSharesReturnOnInvestedCapitalMember 2020-01-01 2020-03-31 0000918541 nnbr:PerformanceSharesTsrAwardsMember 2021-03-31 0000918541 nnbr:PerformanceSharesReturnOnInvestedCapitalMember 2021-03-31 0000918541 nnbr:PerformanceSharesTsrAwardsMember 2020-12-31 0000918541 nnbr:PerformanceSharesReturnOnInvestedCapitalMember 2020-12-31 0000918541 us-gaap:AccumulatedTranslationAdjustmentMember 2020-12-31 0000918541 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-12-31 0000918541 nnbr:AOCIAttributableToParentTaxPortionMember 2020-12-31 0000918541 us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0000918541 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-01-01 2021-03-31 0000918541 nnbr:AOCIAttributableToParentTaxPortionMember 2021-01-01 2021-03-31 0000918541 nnbr:LossOnInterestRateSwapMember us-gaap:AccumulatedTranslationAdjustmentMember 2021-01-01 2021-03-31 0000918541 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember nnbr:LossOnInterestRateSwapMember 2021-01-01 2021-03-31 0000918541 nnbr:AOCIAttributableToParentTaxPortionMember nnbr:LossOnInterestRateSwapMember 2021-01-01 2021-03-31 0000918541 nnbr:LossOnInterestRateSwapMember 2021-01-01 2021-03-31 0000918541 us-gaap:AccumulatedTranslationAdjustmentMember 2021-03-31 0000918541 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-03-31 0000918541 nnbr:AOCIAttributableToParentTaxPortionMember 2021-03-31 0000918541 us-gaap:AccumulatedTranslationAdjustmentMember 2019-12-31 0000918541 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2019-12-31 0000918541 nnbr:AOCIAttributableToParentTaxPortionMember 2019-12-31 0000918541 us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000918541 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000918541 nnbr:AOCIAttributableToParentTaxPortionMember 2020-01-01 2020-03-31 0000918541 us-gaap:InterestExpenseMember us-gaap:AccumulatedTranslationAdjustmentMember 2020-01-01 2020-03-31 0000918541 us-gaap:InterestExpenseMember us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-01-01 2020-03-31 0000918541 us-gaap:InterestExpenseMember nnbr:AOCIAttributableToParentTaxPortionMember 2020-01-01 2020-03-31 0000918541 us-gaap:InterestExpenseMember 2020-01-01 2020-03-31 0000918541 us-gaap:AccumulatedTranslationAdjustmentMember 2020-03-31 0000918541 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2020-03-31 0000918541 nnbr:AOCIAttributableToParentTaxPortionMember 2020-03-31 0000918541 us-gaap:EmployeeStockOptionMember 2021-01-01 2021-03-31 0000918541 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-03-31 0000918541 us-gaap:WarrantMember 2021-01-01 2021-03-31 0000918541 us-gaap:WarrantMember 2020-01-01 2020-03-31 0000918541 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0000918541 us-gaap:PreferredStockMember 2020-01-01 2020-03-31 0000918541 us-gaap:SeriesBPreferredStockMember 2021-03-01 2021-03-31 0000918541 us-gaap:FairValueInputsLevel1Member us-gaap:OtherCurrentLiabilitiesMember 2021-03-31 0000918541 us-gaap:FairValueInputsLevel2Member us-gaap:OtherCurrentLiabilitiesMember 2021-03-31 0000918541 us-gaap:FairValueInputsLevel3Member us-gaap:OtherCurrentLiabilitiesMember 2021-03-31 0000918541 us-gaap:FairValueInputsLevel1Member us-gaap:OtherNoncurrentLiabilitiesMember 2021-03-31 0000918541 us-gaap:FairValueInputsLevel2Member us-gaap:OtherNoncurrentLiabilitiesMember 2021-03-31 0000918541 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2021-03-31 0000918541 us-gaap:FairValueInputsLevel1Member 2021-03-31 0000918541 us-gaap:FairValueInputsLevel2Member 2021-03-31 0000918541 us-gaap:FairValueInputsLevel3Member 2021-03-31 0000918541 us-gaap:FairValueInputsLevel1Member us-gaap:OtherCurrentLiabilitiesMember 2020-12-31 0000918541 us-gaap:FairValueInputsLevel2Member us-gaap:OtherCurrentLiabilitiesMember 2020-12-31 0000918541 us-gaap:FairValueInputsLevel3Member us-gaap:OtherCurrentLiabilitiesMember 2020-12-31 0000918541 us-gaap:FairValueInputsLevel1Member us-gaap:OtherNoncurrentLiabilitiesMember 2020-12-31 0000918541 us-gaap:FairValueInputsLevel2Member us-gaap:OtherNoncurrentLiabilitiesMember 2020-12-31 0000918541 us-gaap:OtherNoncurrentLiabilitiesMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0000918541 us-gaap:FairValueInputsLevel1Member 2020-12-31 0000918541 us-gaap:FairValueInputsLevel2Member 2020-12-31 0000918541 us-gaap:FairValueInputsLevel3Member 2020-12-31 0000918541 srt:MinimumMember 2021-01-01 2021-03-31 0000918541 srt:MaximumMember 2021-01-01 2021-03-31 0000918541 srt:MaximumMember 2020-01-01 2020-12-31 0000918541 srt:MinimumMember 2020-01-01 2020-12-31 0000918541 us-gaap:InterestRateSwapMember 2020-12-31 0000918541 us-gaap:InterestRateSwapMember 2021-01-01 2021-03-31 0000918541 us-gaap:InterestRateSwapMember 2020-01-01 2020-03-31 0000918541 us-gaap:FairValueInputsLevel1Member us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000918541 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateSwapMember us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0000918541 us-gaap:InterestRateSwapMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2021
OR

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to
Commission File Number 000-23486

NN, Inc.
(Exact name of registrant as specified in its charter)

Delaware |  | 62-1096725
(State or other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification Number)

6210 Ardrey Kell Road, Suite 600
Charlotte, North Carolina 28277
(Address of principal executive offices, including zip code)
(980) 264-4300
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class |  | Trading symbol |  | Name of each exchange on which registered
Common Stock, par value $0.01 per share |  | NNBR |  | The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer |  | ☐ |  | Accelerated filer |  | ☒
Non-accelerated filer |  | ☐ |  | Smaller reporting company |  | ☒
|  |  |  | Emerging growth company |  | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of May 3, 2021, there were 43,064,365 shares of the registrant’s common stock, par value $0.01 per share, outstanding.

Table of Contents
NN, Inc.
INDEX

|  | Page
PART I. FINANCIAL INFORMATION | 3
Item 1. | Financial Statements | 3
| Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) (Unaudited) | 3
| Condensed Consolidated Balance Sheets (Unaudited) | 4
| Condensed Consolidated Statement of Changes in Stockholders’ Equity (Unaudited) | 5
| Condensed Consolidated Statements of Cash Flows (Unaudited) | 6
| Notes to Condensed Consolidated Financial Statements (Unaudited) | 7
| Note 1. Interim Financial Statements | 7
| Note 2. Discontinued Operations | 8
| Note 3. Segment Information | 9
| Note 4. Inventories | 10
| Note 5. Goodwill | 10
| Note 6. Intangible Assets, Net | 11
| Note 7. Investment in Joint Venture | 11
| Note 8. Income Taxes | 11
| Note 9. Debt | 11
| Note 10. Leases | 13
| Note 11. Commitments and Contingencies | 13
| Note 12. Preferred Stock and Stockholders' Equity | 14
| Note 13. Revenue from Contracts with Customers | 16
| Note 14. Share-Based Compensation | 17
| Note 15. Accumulated Other Comprehensive Income | 20
| Note 16. Net Income (Loss) Per Common Share | 20
| Note 17. Fair Value Measurements | 22
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 25
Item 3. | Quantitative and Qualitative Disclosures About Market Risk | 30
Item 4. | Controls and Procedures | 31
PART II. OTHER INFORMATION | 32
Item 1. | Legal Proceedings | 32
Item 1A. | Risk Factors | 32
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 32
Item 3. | Defaults U pon Senior Securities | 32
Item 4. | Mine Safety Disclosures | 32
Item 5. | Other Information | 32
Item 6. | Exhibits | 33
SIGNATURES | 34

2

Table of Contents
PART I. FINANCIAL INFORMATION
Item 1.Financial Statements
NN, Inc.
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
(Unaudited)

|  | Three Months Ended March 31, |  |
(in thousands, except per share data) |  | 2021 |  | 2020 |  |  |  |  |  |
Net sales |  | $ | 126,804 |  |  | $ | 116,213 |  |  |  |  |  |  |
Cost of sales (exclusive of depreciation and amortization shown separately below) |  | 99,688 |  |  | 94,478 |  |  |  |  |  |  |
Selling, general, and administrative expense |  | 14,575 |  |  | 16,160 |  |  |  |  |  |  |
Depreciation and amortization |  | 11,568 |  |  | 11,357 |  |  |  |  |  |  |
Goodwill impairment |  | — |  |  | 92,942 |  |  |  |  |  |  |
Other operating expense (income), net |  | (5) |  |  | 5,126 |  |  |  |  |  |  |
Income (loss) from operations |  | 978 |  |  | (103,850) |  |  |  |  |  |  |
Interest expense |  | 2,024 |  |  | 3,807 |  |  |  |  |  |  |
Loss on extinguishment of debt and write-off of debt issuance costs |  | 2,390 |  |  | — |  |  |  |  |  |  |
Derivative payments on interest rate swap |  | 1,717 |  |  | — |  |  |  |  |  |  |
Loss on interest rate swap |  | 2,033 |  |  | — |  |  |  |  |  |  |
Other expense (income), net |  | (122) |  |  | 1,544 |  |  |  |  |  |  |
Loss from continuing operations before benefit for income taxes and share of net income (loss) from joint venture |  | (7,064) |  |  | (109,201) |  |  |  |  |  |  |
Benefit for income taxes |  | 756 |  |  | 1,395 |  |  |  |  |  |  |
Share of net income (loss) from joint venture |  | 1,395 |  |  | (271) |  |  |  |  |  |  |
Loss from continuing operations |  | (4,913) |  |  | (108,077) |  |  |  |  |  |  |
Loss from discontinued operations, net of tax (Note 2) |  | — |  |  | (140,114) |  |  |  |  |  |  |
Net loss |  | $ | (4,913) |  |  | $ | (248,191) |  |  |  |  |  |  |
Other comprehensive loss: |  |  |  |  |  |  |  |  |  |
Foreign currency translation loss |  | (3,347) |  |  | (14,342) |  |  |  |  |  |  |
Interest rate swap: |  |  |  |  |  |  |  |  |  |
Change in fair value, net of tax |  | — |  |  | (11,209) |  |  |  |  |  |  |
Reclassification adjustment for losses included in net loss, net of tax |  | 2,851 |  |  | 1,052 |  |  |  |  |  |  |
Other comprehensive loss |  | $ | (496) |  |  | $ | (24,499) |  |  |  |  |  |  |
Comprehensive loss |  | $ | (5,409) |  |  | $ | (272,690) |  |  |  |  |  |  |
Basic net loss per common share: |  |  |  |  |  |  |  |  |  |
Loss from continuing operations per common share |  | $ | (0.46) |  |  | $ | (2.64) |  |  |  |  |  |  |
Loss from discontinued operations per common share |  | — |  |  | (3.32) |  |  |  |  |  |  |
Net loss per common share |  | $ | (0.46) |  |  | $ | (5.96) |  |  |  |  |  |  |
Weighted average common shares outstanding |  | 42,672 |  |  | 42,111 |  |  |  |  |  |  |
Diluted net loss per common share: |  |  |  |  |  |  |  |  |  |
Loss from continuing operations per common share |  | $ | (0.46) |  |  | $ | (2.64) |  |  |  |  |  |  |
Loss from discontinued operations per common share |  | — |  |  | (3.32) |  |  |  |  |  |  |
Net loss per common share |  | $ | (0.46) |  |  | $ | (5.96) |  |  |  |  |  |  |
Weighted average common shares outstanding |  | 42,672 |  |  | 42,111 |  |  |  |  |  |  |

See notes to condensed consolidated financial statements (unaudited).
3

Table of Contents
NN, Inc.
Condensed Consolidated Balance Sheets
(Unaudited)

(in thousands, except per share data) |  | March 31, 2021 |  | December 31, 2020
Assets |  |  |  |
Current assets: |  |  |  |
Cash and cash equivalents |  | $ | 43,033 |  |  | $ | 48,138 |
Accounts receivable, net |  | 90,545 |  |  | 84,615 |
Inventories |  | 67,531 |  |  | 62,517 |
Income tax receivable |  | 8,956 |  |  | 8,800 |
Other current assets |  | 12,431 |  |  | 11,148 |
Total current assets |  | 222,496 |  |  | 215,218 |
Property, plant and equipment, net |  | 218,057 |  |  | 223,690 |
Operating lease right-of-use assets |  | 49,545 |  |  | 50,264 |
Intangible assets, net |  | 99,479 |  |  | 103,065 |
Investment in joint venture |  | 28,207 |  |  | 26,983 |
Other non-current assets |  | 4,532 |  |  | 5,742 |
Total assets |  | $ | 622,316 |  |  | $ | 624,962 |
Liabilities, Preferred Stock, and Stockholders’ Equity |  |  |  |
Current liabilities: |  |  |  |
Accounts payable |  | $ | 43,232 |  |  | $ | 37,435 |
Accrued salaries, wages and benefits |  | 24,613 |  |  | 21,296 |
Income tax payable |  | 3,376 |  |  | 3,557 |
Current maturities of long-term debt |  | 4,844 |  |  | 4,885 |
Current portion of operating lease liabilities |  | 4,963 |  |  | 4,797 |
Other current liabilities |  | 17,042 |  |  | 31,261 |
Total current liabilities |  | 98,070 |  |  | 103,231 |
Deferred tax liabilities |  | 10,326 |  |  | 11,178 |
Long-term debt, net of current portion |  | 151,551 |  |  | 79,025 |
Operating lease liabilities, net of current portion |  | 54,780 |  |  | 55,053 |
Other non-current liabilities |  | 25,976 |  |  | 17,237 |
Total liabilities |  | 340,703 |  |  | 265,724 |
Commitments and contingencies (Note 11) |  |  |  |
Series D perpetual preferred stock - $0.01 par value per share, 5,000 shares authorized, 65 shares issued and outstanding at March 31, 2021 |  | 46,858 |  |  | — |
Series B convertible preferred stock - $0.01 par value per share, 100 shares authorized, 100 shares issued and outstanding at December 31, 2020 |  | — |  |  | 105,086 |
Stockholders' equity: |  |  |  |
Common stock - $0.01 par value per share, 90,000 shares authorized, 42,686 and 43,049 shares issued and outstanding at December 31, 2020 and March 31, 2021, respectively |  | 430 |  |  | 427 |
Additional paid-in capital |  | 479,341 |  |  | 493,332 |
Accumulated deficit |  | (210,788) |  |  | (205,875) |
Accumulated other comprehensive loss |  | (34,228) |  |  | (33,732) |
Total stockholders’ equity |  | 234,755 |  |  | 254,152 |
Total liabilities, preferred stock, and stockholders’ equity |  | $ | 622,316 |  |  | $ | 624,962 |

See notes to condensed consolidated financial statements (unaudited).
4

Table of Contents
NN, Inc.
Condensed Consolidated Statements of Changes in Stockholders’ Equity
Three Months Ended March 31, 2021 and 2020
(Unaudited)

|  | Common Stock |  |  |  |  |  |  |  |  |  |
(in thousands) |  | Number of shares |  | Par value |  | Additional paid-in capital |  |  |  | Accumulated deficit |  | Accumulated other comprehensive income (loss) |  | Total
Balance, December 31, 2020 |  | 42,686 |  |  | $ | 427 |  |  | $ | 493,332 |  |  |  |  | $ | (205,875) |  |  | $ | (33,732) |  |  | $ | 254,152 |
Net loss |  | — |  |  | — |  |  | — |  |  |  |  | (4,913) |  |  | — |  |  | (4,913) |
Dividends accrued for preferred stock |  | — |  |  | — |  |  | (14,529) |  |  |  |  | — |  |  | — |  |  | (14,529) |
Share-based compensation expense |  | 413 |  |  | 4 |  |  | 882 |  |  |  |  | — |  |  | — |  |  | 886 |
Restricted shares forgiven for taxes |  | (50) |  |  | (1) |  |  | (344) |  |  |  |  | — |  |  | — |  |  | (345) |
Reclassification of interest rate swap to net loss, net of tax of $861 |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | 2,851 |  |  | 2,851 |
Foreign currency translation loss |  | — |  |  | — |  |  | — |  |  |  |  | — |  |  | (3,347) |  |  | (3,347) |
Balance, March 31, 2021 |  | 43,049 |  |  | $ | 430 |  |  | $ | 479,341 |  |  |  |  | $ | (210,788) |  |  | $ | (34,228) |  |  | $ | 234,755 |

|  | Common Stock |  |  |  |  |  |  |  |  |  |
(in thousands) |  | Number of shares |  | Par value |  | Additional paid-in capital |  | Warrants |  | Accumulated deficit |  | Accumulated other comprehensive income (loss) |  | Total
Balance, December 31, 2019 |  | 42,313 |  |  | $ | 423 |  |  | $ | 501,615 |  |  | $ | 1,076 |  |  | $ | (105,283) |  |  | $ | (44,554) |  |  | $ | 353,277 |
Net loss |  | — |  |  | — |  |  | — |  |  | — |  |  | (248,191) |  |  | — |  |  | (248,191) |
Dividends accrued for preferred stock |  | — |  |  | — |  |  | (2,951) |  |  | — |  |  | — |  |  | — |  |  | (2,951) |
Share-based compensation expense |  | 452 |  |  | 5 |  |  | 1,291 |  |  | — |  |  | — |  |  | — |  |  | 1,296 |
Restricted shares forgiven for taxes |  | (8) |  |  | — |  |  | (30) |  |  | — |  |  | — |  |  | — |  |  | (30) |
Change in fair value of interest rate swap, net of tax of $3,390 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (11,209) |  |  | (11,209) |
Reclassification of interest rate swap settlement to net loss, net of tax of $318 |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 1,052 |  |  | 1,052 |
Foreign currency translation loss |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (14,342) |  |  | (14,342) |
Balance, March 31, 2020 |  | 42,757 |  |  | $ | 428 |  |  | $ | 499,925 |  |  | $ | 1,076 |  |  | $ | (353,474) |  |  | $ | (69,053) |  |  | $ | 78,902 |

See notes to condensed consolidated financial statements (unaudited).
5

Table of Contents
NN, Inc.
Condensed Consolidated Statements of Cash Flows
(Unaudited)

|  | Three Months Ended March 31, |  |
(in thousands) |  | 2021 |  | 2020 |  |
Cash flows from operating activities |  |  |  |  |  |
Net loss |  | $ | (4,913) |  |  | $ | (248,191) |  |  |
Adjustments to reconcile net loss to net cash provided by operating activities: |  |  |  |  |  |
Depreciation and amortization of continuing operations |  | 11,568 |  |  | 11,357 |  |  |
Depreciation and amortization of discontinued operations |  | — |  |  | 11,827 |  |  |
Amortization of debt issuance costs |  | 405 |  |  | 1,652 |  |  |
Goodwill impairment of continuing operations |  | — |  |  | 92,942 |  |  |
Goodwill impairment of discontinued operations |  | — |  |  | 146,757 |  |  |
Loss on extinguishment of debt and write-off of debt issuance costs |  | 2,390 |  |  | — |  |  |
Total derivative loss, net of cash settlements |  | 3,750 |  |  | — |  |  |
Share of net income (loss) from joint venture, net of cash dividends received |  | (1,395) |  |  | 271 |  |  |
Compensation expense from issuance of share-based awards |  | 886 |  |  | 1,296 |  |  |
Deferred income taxes |  | (1,605) |  |  | (3,923) |  |  |
Other |  | (1,081) |  |  | 614 |  |  |
Changes in operating assets and liabilities: |  |  |  |  |  |
Accounts receivable |  | (6,684) |  |  | 1,760 |  |  |
Inventories |  | (5,589) |  |  | (2,507) |  |  |
Accounts payable |  | 7,094 |  |  | 3,584 |  |  |
Income taxes receivable and payable, net |  | (344) |  |  | (12,676) |  |  |
Other |  | 3,402 |  |  | 5,461 |  |  |
Net cash provided by operating activities |  | 7,884 |  |  | 10,224 |  |  |
Cash flows from investing activities |  |  |  |  |  |
Acquisition of property, plant and equipment |  | (5,468) |  |  | (11,260) |  |  |
Proceeds from sale of property, plant, and equipment |  | 11 |  |  | 82 |  |  |
Cash settlements of interest rate swap |  | (15,420) |  |  | — |  |  |
Net cash used in investing activities |  | (20,877) |  |  | (11,178) |  |  |
Cash flows from financing activities |  |  |  |  |  |
Cash paid for debt issuance costs |  | (6,856) |  |  | (286) |  |  |
Proceeds from issuance of preferred stock |  | 61,918 |  |  | — |  |  |
Redemption of preferred stock |  | (122,434) |  |  | — |  |  |
Proceeds from long-term debt |  | 150,000 |  |  | 60,012 |  |  |
Repayments of long-term debt |  | (70,721) |  |  | (4,527) |  |  |
Repayments of short-term debt, net |  | (1,090) |  |  | (411) |  |  |
Other |  | (1,189) |  |  | (888) |  |  |
Net cash provided by financing activities |  | 9,628 |  |  | 53,900 |  |  |
Effect of exchange rate changes on cash flows |  | (1,740) |  |  | (5,435) |  |  |
Net change in cash and cash equivalents |  | (5,105) |  |  | 47,511 |  |  |
Cash and cash equivalents at beginning of period (1) |  | 48,138 |  |  | 31,703 |  |  |
Cash and cash equivalents at end of period (1) |  | $ | 43,033 |  |  | $ | 79,214 |  |  |

_______________________________
(1) Cash and cash equivalents include $11.7 million and $13.8 million of cash and cash equivalents that were included in current assets of discontinued operations as of March 31, 2020, and December 31, 2019, respectively.
See notes to condensed consolidated financial statements (unaudited).
6

Table of Contents
NN, Inc.
Notes to Condensed Consolidated Financial Statements
March 31, 2021
(Unaudited)
Amounts in thousands, except per share data
Note 1. Interim Financial Statements
Nature of Business
NN, Inc. is a global diversified industrial company that combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies primarily for the automotive, general industrial, electrical, aerospace and defense, and medical markets. As used in this Quarterly Report on Form 10-Q (this “Quarterly Report”), the terms “NN,” the “Company,” “we,” “our,” or “us” refer to NN, Inc., and its subsidiaries.
Basis of Presentation
The accompanying condensed consolidated financial statements have not been audited. The Condensed Consolidated Balance Sheet as of December 31, 2020, was derived from the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2020 (the “2020 Annual Report”), which we filed with the U.S. Securities and Exchange Commission (the “SEC”) on March 15, 2021. Historical periods presented reflect reclassifications for discontinued operations (see Note 2). In management’s opinion, the accompanying unaudited condensed consolidated financial statements reflect all adjustments necessary to fairly state our results of operations for the three months ended March 31, 2021 and 2020; financial position as of March 31, 2021, and December 31, 2020; and cash flows for the three months ended March 31, 2021 and 2020, on a basis consistent with our audited consolidated financial statements other than the adoption of new accounting standards (see Accounting Standards Recently Adopted section below). These adjustments are of a normal recurring nature and are, in the opinion of management, necessary to state fairly the Company’s financial position and operating results for the interim periods.
Certain information and footnote disclosures normally included in the consolidated financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted from the interim financial statements presented in this Quarterly Report. These unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements and accompanying notes included in the 2020 Annual Report. The results for the three months ended March 31, 2021, are not necessarily indicative of results for the year ending December 31, 2021, or any other future periods.
Except for per share data or as otherwise indicated, all U.S. dollar amounts presented in the tables in these Notes to Condensed Consolidated Financial Statements are in thousands.
Accounting Standards Recently Adopted
In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740) - Simplifying the Accounting for Income Taxes, (“ASU 2019-12”) as part of its initiative to reduce complexity in accounting standards. ASU 2019-12 removes certain exceptions and provides simplification to specific tax items to improve consistent application. This standard was effective for us beginning January 1, 2021. The adoption of ASU 2019-12 did not have a material impact on our consolidated financial statements and related disclosures.
Accounting Standards Not Yet Adopted
In August 2020, the FASB issued ASU 2020-06, Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity, (“ASU 2020-06”) which simplifies the accounting for certain financial instruments with characteristics of liabilities and equity. Specifically, ASU 2020-06 simplifies accounting for convertible instruments by removing major separation models required under current U.S. GAAP. In addition, ASU 2020-06 removes certain settlement conditions that are required for equity contracts to qualify for the derivative scope exception, which will permit more equity contracts to qualify for the exception. Further, for the diluted earnings-per-share calculation, the new guidance requires entities to use the if-converted method for all convertible instruments and generally requires entities to include the effect of share settlement for instruments that may be settled in cash or shares, among other things. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, and interim periods within those fiscal years, with early adoption permitted. Either the full or modified retrospective adoption method is allowed. We are currently evaluating the impact on our consolidated financial statements and related disclosures.
7

Table of Contents
Note 2. Discontinued Operations
In October 2020, we closed on the sale of our Life Sciences business under the terms of a Stock Purchase Agreement (the “SPA”) with affiliates of American Securities LLC for $753.3 million cash. The SPA includes a potential earnout payment of up to $70 million based on the performance of the Life Sciences business during the year ending December 31, 2022, measured by Adjusted EBITDA targets, as defined by the SPA. After working capital and other closing adjustments, we received cash proceeds at closing of $757.2 million and have recorded a $3.9 million payable as of March 31, 2021, and December 31, 2020, for the balance.
Under the terms of a transition services agreement, we provided certain support services after the sale. In accordance with the terms of the SPA, we agreed to indemnify the buyer for certain tax liabilities on its consolidated federal income tax return related to the Life Sciences business during the portion of the year ended December 31, 2020, prior to the change in ownership on October 6, 2020. We estimate that the tax indemnification will result in a payment of approximately $1.2 million to the buyer during the year ending December 31, 2021, and we have recorded this estimated obligation in the “Other current liabilities” line item on the Condensed Consolidated Balance Sheets as of March 31, 2021, and December 31, 2020.
In accordance with ASC 205-20, Presentation of Financial Statements - Discontinued Operations, the operating results of the Life Sciences business are classified as discontinued operations. The presentation of discontinued operations includes revenues and expenses of the discontinued operations as well as any gain on the disposition of the business, all net of tax, as one line item on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). The Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) for all historical periods presented have been revised to reflect this presentation. Accordingly, the results of the Life Sciences business have been excluded from continuing operations and segment results for all historical periods presented in the condensed consolidated financial statements and the accompanying notes unless otherwise stated. The Condensed Consolidated Statements of Cash Flows for historical periods include cash flows of the Life Sciences business in each line item unless otherwise stated.
The following table presents the operating results of the discontinued operations.

|  |  |  | Three Months Ended March 31, 2020 |  |  |  |
Net sales |  |  |  | $ | 83,532 |  |  |  |  |
Cost of sales (exclusive of depreciation and amortization shown separately below) |  |  |  | 57,763 |  |  |  |  |
Selling, general, and administrative expense |  |  |  | 8,405 |  |  |  |  |
Depreciation and amortization |  |  |  | 11,827 |  |  |  |  |
Goodwill impairment |  |  |  | 146,757 |  |  |  |  |
Other operating expense, net |  |  |  | 3 |  |  |  |  |
Loss from operations |  |  |  | (141,223) |  |  |  |  |
Interest expense |  |  |  | 13,270 |  |  |  |  |
Other income, net |  |  |  | (424) |  |  |  |  |
Loss from discontinued operations before costs of disposal and benefit for income taxes |  |  |  | (154,069) |  |  |  |  |
Benefit for income taxes |  |  |  | 14,187 |  |  |  |  |
Loss from discontinued operations before costs of disposal |  |  |  | (139,882) |  |  |  |  |
Costs of disposal of discontinued operations (1) |  |  |  | (259) |  |  |  |  |
Benefit for income taxes on costs of disposal |  |  |  | 27 |  |  |  |  |
Loss from discontinued operations, net of tax |  |  |  | $ | (140,114) |  |  |  |  |

_______________________________
(1)Represents incremental direct costs related to the sale of the Life Sciences business that were incurred prior to the closing of the sale.
During the first quarter of 2020, our market capitalization declined to a level that was less than the net book value of our stockholders’ equity. The decline in market capitalization was a triggering event that caused us to perform a goodwill impairment analysis as of March 31, 2020. The carrying value of the Life Sciences reporting unit exceeded its estimated fair value as of March 31, 2020. As a result of our analysis, we recorded an impairment loss on goodwill of $146.8 million for Life
8

Table of Contents
Sciences. The judgments, assumptions, and estimates involved in the goodwill impairment analysis for the Life Sciences reporting unit are consistent with those discussed in Note 5.
Our previous credit facility, which was in place at the time, required us to use proceeds from the sale of the Life Sciences business to prepay a portion of our previous debt. We paid $700 million in the aggregate on our term loans immediately after the transaction closed on October 6, 2020. The prepayment was applied to debt in accordance with the prepayment provisions of the previous credit agreement which was in place at the time. Average quarterly interest rates were multiplied by the required prepayment amounts to calculate interest expense to be reclassified to discontinued operations for historical periods presented. The following table summarizes the amount of interest expense related to the previous credit facility that has been reclassified to discontinued operations.

|  |  |  | Three Months Ended March 31, 2020 |  |  |  |
Interest on debt |  |  |  | $ | 12,136 |  |  |  |  |
Amortization of debt issuance costs |  |  |  | 1,226 |  |  |  |  |
Capitalized interest and other |  |  |  | (223) |  |  |  |  |
Other |  |  |  | 131 |  |  |  |  |
Total interest expense of discontinued operations |  |  |  | $ | 13,270 |  |  |  |  |

The following table presents the significant noncash items and cash paid for capital expenditures of discontinued operations for each historical period presented.

|  |  |  | Three Months Ended March 31, 2020
Depreciation and amortization |  |  |  | $ | 11,827 |
Goodwill impairment |  |  |  | 146,757 |
Amortization of debt issuance costs |  |  |  | 1,226 |
Acquisition of property, plant and equipment |  |  |  | 4,084 |
Right-of-use assets obtained in exchange for new finance lease liabilities |  |  |  | 694 |

Note 3. Segment Information
Our business is aggregated into the following two reportable segments:
•Mobile Solutions, which is focused on growth in the automotive and general industrial end markets; and
•Power Solutions, which is focused on growth in the electrical, general industrial, automotive, and aerospace and defense, and medical end markets.
These divisions are considered our two operating segments as each engages in business activities for which it earns revenues and incurs expenses, discrete financial information is available for each, and this is the level at which the chief operating decision maker reviews discrete financial information for purposes of allocating resources and assessing performance. Historically, we had a third operating segment, Life Sciences, that was focused on growth in the medical end market. See Note 2 for information regarding the sale of the Life Sciences business on October 6, 2020. The results of the Life Sciences business are classified as discontinued operations for the three months ended March 31, 2020, and therefore are not included in the tabular presentation below.
9

Table of Contents
The following tables present results of continuing operations by reportable segment.

|  |  | Mobile Solutions |  | Power Solutions |  | Corporate and Consolidations |  |  |  | Total
Three Months Ended March 31, 2021 |  |  |  |  |  |  |  |  |  |  |
Net sales |  |  | $ | 77,776 |  |  | $ | 49,075 |  |  | $ | (47) |  |  | (a) |  | $ | 126,804 |
Income (loss) from operations |  |  | 6,090 |  |  | 2,432 |  |  | (7,544) |  |  |  |  | $ | 978 |
Interest expense |  |  |  |  |  |  |  |  |  |  | (2,024) |
Other |  |  |  |  |  |  |  |  |  |  | (6,018) |
Loss from continuing operations before income taxes and share of net income from joint venture |  |  |  | $ | (7,064) |
Three Months Ended March 31, 2020 |  |  |  |  |  |  |  |  |  |  |
Net sales |  |  | $ | 69,884 |  |  | $ | 46,401 |  |  | $ | (72) |  |  | (a) |  | $ | 116,213 |
Goodwill impairment |  |  | — |  |  | 92,942 |  |  | — |  |  |  |  | $ | 92,942 |
Income (loss) from operations |  |  | 264 |  |  | (90,334) |  |  | (13,780) |  |  |  |  | $ | (103,850) |
Interest expense |  |  |  |  |  |  |  |  |  |  | (3,807) |
Other |  |  |  |  |  |  |  |  |  |  | (1,544) |
Loss from continuing operations before income taxes and share of net loss from joint venture |  |  |  | $ | (109,201) |

_______________________________
(a)Includes elimination of intersegment transactions occurring during the ordinary course of business.
As of March 31, 2021, and December 31, 2020, one customer represented 10% and 11%, respectively, of consolidated accounts receivable. Amounts due from this customer are primarily related to Mobile Solutions.
Note 4. Inventories
Inventories are comprised of the following amounts:

|  | March 31, 2021 |  | December 31, 2020
Raw materials |  | $ | 23,605 |  |  | $ | 22,589 |
Work in process |  | 22,626 |  |  | 20,758 |
Finished goods |  | 21,300 |  |  | 19,170 |
Total inventories |  | $ | 67,531 |  |  | $ | 62,517 |

Note 5. Goodwill
During the first quarter of 2020, our market capitalization declined to a level that was less than the net book value of our stockholders’ equity. The decline in market capitalization was a triggering event that caused us to perform a goodwill impairment analysis as of March 31, 2020. The goodwill impairment analysis required significant judgments to calculate the fair value for the Power Solutions reporting unit, including estimation of future cash flows, which is dependent on internal forecasts, estimation of the long-term growth rate for the operating segment, and determination of weighted average cost of capital. Our forecasts used in the goodwill impairment analysis reflected our expectations of declines in sales resulting from COVID-19. Significant assumptions and estimates are involved in the application of the discounted cash flow model to forecast operating cash flows, including market growth and market share, sales volumes and prices, costs to produce, discount rate, and estimated capital needs. Management considers historical experience and all available information at the time the fair values of its reporting units are estimated. Assumptions in estimating future cash flows are subject to a high degree of judgment and complexity. The carrying value of the Power Solutions reporting unit exceeded the estimated fair value as of the March 31, 2020, analysis. As a result of our analysis, we recorded an impairment loss on goodwill of $92.9 million to the “Goodwill impairment” line on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). As of March 31, 2021, and December 31, 2020, there was no remaining goodwill balance.
10

Table of Contents
Note 6. Intangible Assets, Net
The following table shows changes in the carrying amount of intangible assets, net, by reportable segment.

|  |  |  | Mobile Solutions |  | Power Solutions |  | Total
Balance as of December 31, 2020 |  |  |  | $ | 29,062 |  |  | $ | 74,003 |  |  | $ | 103,065 |
Amortization |  |  |  | (838) |  |  | (2,748) |  |  | (3,586) |
Balance as of March 31, 2021 |  |  |  | $ | 28,224 |  |  | $ | 71,255 |  |  | $ | 99,479 |

Intangible assets are tested for impairment when changes in circumstances indicate the carrying value of those assets may not be recoverable. As of March 31, 2021, and December 31, 2020, there were no indicators of impairment.
Note 7. Investment in Joint Venture
We own a 49% investment in Wuxi Weifu Autocam Precision Machinery Company, Ltd. (the “JV”), a joint venture located in Wuxi, China. The JV is jointly controlled and managed, and we account for it under the equity method.
The following table shows changes in our investment in the JV.

Balance as of December 31, 2020 | $ | 26,983 |
Share of earnings | 1,395 |
Foreign currency translation loss | (171) |
Balance as of March 31, 2021 | $ | 28,207 |

Note 8. Income Taxes
Our effective tax rate for continuing operations was 10.7% and 1.3% for the three months ended March 31, 2021 and 2020, respectively. The effective tax rate for the three months ended March 31, 2021, differs from the U.S. federal statutory tax rate of 21% primarily due to the accrual of tax on non-permanently reinvested unremitted earnings of foreign subsidiaries and by limitation on the amount of tax benefit recorded for loss carryforwards in certain jurisdictions where we believe it is more likely than not a portion of the future tax benefit may not be realized. In addition, the effective tax rate was unfavorably impacted by U.S. tax on the earnings of foreign subsidiaries under the global intangible low-taxed income (“GILTI”) regime.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) was enacted. The provisions of the legislation had a significant impact on the effective tax rate and income tax receivable of the Company for the three months ended March 31, 2020. Under the CARES Act, NOLs arising in tax years beginning after December 31, 2017, were carried back to preceding tax years when the federal tax rate was 35% rather than the currently enacted 21%. The effective tax rate for the three months ended March 31, 2020, was also adversely impacted by the non-deductible goodwill impairment recorded in that period, partially offset by impacts from the CARES Act.
Note 9. Debt
On March 22, 2021, we entered into a new $150.0 million term loan facility (the “Term Loan Facility”) and a new $50.0 million asset backed credit facility (the “ABL Facility”). The proceeds from the Term Loan Facility were used to prepay the amounts outstanding on our previous term loans. The previous credit facility was terminated and consisted of a Senior Secured Term Loan, Incremental Term Loan, and Senior Secured Revolver. No amounts were outstanding on the Senior Secured Revolver at the time of termination.
11

Table of Contents
The following table presents debt balances as of March 31, 2021, and December 31, 2020.

|  | March 31, 2021 |  | December 31, 2020
Term Loan Facility |  | $ | 150,000 |  |  | $ | — |
Senior Secured Term Loan |  | — |  |  | 47,728 |
Incremental Term Loan |  | — |  |  | 22,716 |
International lines of credit and other loans |  | 12,547 |  |  | 14,418 |
Total principal |  | 162,547 |  |  | 84,862 |
Less-current maturities of long-term debt |  | 4,844 |  |  | 4,885 |
Principal, net of current portion |  | 157,703 |  |  | 79,977 |
Less-unamortized debt issuance costs (1) |  | 6,152 |  |  | 952 |
Long-term debt, net of current portion |  | $ | 151,551 |  |  | $ | 79,025 |

_______________________________
(1) In addition to this amount, costs of $0.8 million related to the ABL Facility are recorded in other non-current assets as of March 31, 2021, and $1.8 million related to the Senior Secured Revolver are recorded in other non-current assets as of December 31, 2020.
Term Loan Facility
Outstanding borrowings under the Term Loan Facility bear interest at either 1) one-month LIBOR (subject to a 1.000% floor) plus an applicable margin of 6.875% or 2) the greater of various benchmark rates plus an applicable margin of 5.875%. At March 31, 2021, the Term Loan Facility bore interest based on one-month LIBOR at 7.875%.
The Term Loan Facility requires quarterly principal payments of $0.4 million with the remaining unpaid principal amount due on the final maturity date of September 22, 2026. The Term Loan Facility is collateralized by all of our assets. The Term Loan Facility has a first lien on all assets other than accounts receivable and inventory and has a second lien on accounts receivable and inventory. We were in compliance with all requirements under the Term Loan Facility as of March 31, 2021.
The Term Loan Facility was issued at a $3.8 million discount. We capitalized a total of $2.4 million in new debt issuance costs related to the Term Loan Facility. Debt issuance costs and original issue discount related to the Term Loan Facility are recorded as a direct reduction to the carrying amount of the associated long-term debt and amortized over the term of the debt.
ABL Facility
The ABL Facility provides for a senior secured revolving credit facility in the amount of $50.0 million, of which $30.0 million is available in the form of letters of credit and $5.0 million is available for the issuance of short-term swingline loans. The availability of credit under the ABL Facility is limited by a borrowing base calculation derived from accounts receivable and inventory held in the United States. Outstanding borrowings under the ABL Facility bear interest on a variable rate structure plus an interest rate spread that is based on the average amount of aggregate revolving commitment available. The variable borrowing rate is either 1) LIBOR plus an applicable margin of 1.75% or 2.00%, depending on availability, or 2) the greater of the federal funds rate or prime, plus an applicable margin of 0.75% or 1.00%, depending on availability. We may elect whether to use one-month, three-month, or six-month LIBOR, subject to a 0.50% floor. Interest payments are due monthly on borrowings that utilize one-month LIBOR and quarterly on borrowings that utilize three-month or six-month LIBOR. At March 31, 2021, using one-month LIBOR plus a 1.75% spread, the weighted average interest rate on outstanding borrowings under the ABL Facility would have been 2.25% if there had been any balance outstanding. We pay a commitment fee of 0.375% for unused capacity under the ABL Facility and a 0.125% fee on the amount of letters of credit outstanding. The final maturity date of the ABL Facility is March 22, 2026.
We had no outstanding borrowings under the ABL Facility at March 31, 2021. Total capacity under the ABL Facility was $47.3 million as of March 31, 2021, with $32.9 million available for future borrowings after reductions for outstanding letters of credit as of March 31, 2021. The ABL Facility has a first lien on accounts receivable and inventory. We were in compliance with all requirements under the ABL Facility as of March 31, 2021.
We capitalized a total of $0.8 million in new debt issuance costs related to the ABL Facility. Costs related to the ABL Facility are recorded in other non-current assets and amortized over the term of the agreement.
Senior Secured Term Loan
Outstanding borrowings under the Senior Secured Term Loan, bore interest at one-month LIBOR (subject to a 0.75% floor) plus an applicable margin of 5.75%. During 2021 until termination, the Senior Secured Term Loan bore interest at 6.50%.
12

Table of Contents
Incremental Term Loan
Outstanding borrowings under the Incremental Term Loan bore interest at one-month LIBOR plus an applicable margin of 5.75%. During 2021 until termination, the Incremental Term Loan bore interest at 5.90%.
Senior Secured Revolver
Outstanding borrowings under the Senior Secured Revolver bore interest on a variable rate structure at either 1) one-month LIBOR plus an applicable margin of 4.00% or 2) the prime lending rate plus an applicable margin of 3.00%. We had no outstanding borrowings under the Senior Secured Revolver during 2021. We incurred a commitment fee of 0.50% for unused capacity under the Senior Secured Revolver until it was terminated.
Debt Issuance Costs
We recognized a $2.4 million loss on extinguishment for unamortized debt issuance costs that were written off in the three months ended March 31, 2021, in connection with the termination of our previous credit facility.
Interest Rate Swap
A portion of the proceeds from the Term Loan Facility was used to settle and terminate our fixed-rate interest rate swap agreement with a cash payment of $13.7 million. Refer to Note 17 for further discussion of the interest rate swap agreement.
Note 10. Leases
The following table contains supplemental cash flow information related to leases of continuing operations.

|  | Three Months Ended March 31, |  |
|  | 2021 |  | 2020 |  |
Cash paid for amounts included in the measurement of lease liabilities: |  |  |  |  |  |
Operating cash flows used in finance leases |  | $ | 57 |  |  | $ | 61 |  |  |
Operating cash flows used in operating leases |  | 4,103 |  |  | 3,348 |  |  |
Financing cash flows used in finance leases |  | 846 |  |  | 580 |  |  |
Right-of-use assets obtained in exchange for new finance lease liabilities |  | 60 |  |  | 710 |  |  |
Right-of-use assets obtained in exchange for new operating lease liabilities (1) |  | — |  |  | 13,241 |  |  |

_______________________________
(1) Includes new leases, renewals, and modifications.
As disclosed in our 2020 Annual Report, we amended the lease of our corporate headquarters building in March 2020 to exit over half of the previously leased space and reduce annual base rent payments. The amendment was accounted for as a lease modification, and the remeasurement of the lease resulted in an $8.1 million decrease in the operating lease right-of-use (“ROU”) asset, a $10.5 million decrease in the noncurrent portion of the operating lease liability, and a $0.6 million decrease in the current portion of the operating lease liability. The $3.0 million difference between the change in the operating lease ROU asset and the operating lease liabilities was recognized in “Other operating expense (income), net,” on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss). In connection with the discontinued use of the previously leased space, we also recognized a $4.4 million termination charge and a $2.9 million impairment charge on the associated leasehold improvements, all of which were also recognized in “Other operating expense (income), net.”
Note 11. Commitments and Contingencies
Brazil ICMS Tax Matter
Prior to the acquisition of Autocam Corporation in 2014 (“Autocam”), Autocam’s Brazilian subsidiary (“Autocam Brazil”) received notification from the Brazilian tax authority regarding ICMS (state value added tax or “VAT”) tax credits claimed on intermediary materials (e.g., tooling and perishable items) used in the manufacturing process. The Brazilian tax authority notification disallowed state ICMS tax credits claimed on intermediary materials based on the argument that these items are not intrinsically related to the manufacturing processes. Autocam Brazil filed an administrative defense with the Brazilian tax
13

Table of Contents
authority arguing, among other matters, that it should qualify for an ICMS tax credit, contending that the intermediary materials are directly related to the manufacturing process.
We believe that we have substantial legal and factual defenses, and we plan to defend our interests in this matter vigorously. The matter encompasses several lawsuits filed with the Brazilian courts requesting declaratory actions that no tax is due or seeking a stay of execution on the collection of the tax. In 2018, we obtained a favorable decision in one of the declaratory actions for which the period for appeal has expired. We have filed actions in each court requesting dismissal of the matter based on the earlier court action. In May 2020, we received an unfavorable decision in one of the lawsuits, and as a result have recorded a liability to the Brazilian tax authorities and a receivable from the former shareholders of Autocam for the same amount. Although we anticipate a favorable resolution to the remaining matters, we can provide no assurances that we will be successful in achieving dismissal of all pending cases. The U.S. dollar amount that would be owed in the event of an unfavorable decision is subject to interest, penalties, and currency impacts and therefore is dependent on the timing of the decision. For the remaining open lawsuits, we currently believe the cumulative potential liability in the event of unfavorable decisions on all matters will be less than $5.0 million, inclusive of interest and penalties.
We are entitled to indemnification from the former shareholders of Autocam, subject to the limitations and procedures set forth in the agreement and plan of merger relating to the Autocam acquisition. Management believes the indemnification would include amounts owed for the tax, interest, and penalties related to this matter. Accordingly, we don’t expect to incur a loss related to this matter even in the event of an unfavorable decision and, therefore, have not accrued an amount for the remaining matters as of March 31, 2021.
Securities Offering Matter
On November 1, 2019, Erie County Employees’ Retirement System, on behalf of a purported class of plaintiffs, filed a complaint in the Supreme Court of the State of New York, County of New York, against the Company, certain of the Company’s current and former officers and directors, and each of the underwriters involved in the Company’s public offering and sale of 14.4 million shares of its common stock pursuant to a preliminary prospectus supplement, dated September 10, 2018, a final prospectus supplement, dated September 13, 2018, and a base prospectus, dated April 19, 2017, relating to the Company’s effective shelf registration statement on Form S-3 (File No. 333-216737) (the “Offering”), which complaint was amended on January 24, 2020. The complaint alleges violations of Sections 11, 12(a)(2), and 15 of the Securities Act of 1933 in connection with the Offering. The plaintiffs seek to represent a class of stockholders who purchased shares of the Company’s common stock in the Offering. The complaint seeks unspecified monetary damages and other relief. The Company believes the complaint and allegations to be without merit and intends to vigorously defend itself against these actions. The Company is unable at this time to determine whether the outcome of the litigation would have a material impact on the Company’s financial position, results of operations, or cash flows.
Other Legal Matters
On October 26, 2020, Corre Opportunities Qualified Master Fund, LP, and Corre Horizon Fund, LP, filed a complaint in the Chancery Court of the State of Delaware against the Company. The complaint alleges that the Company’s sale of its Life Sciences business without obtaining the prior consent of the plaintiffs was a breach of the terms of the Series B Preferred Stock. The complaint seeks unspecified monetary damages and other relief. The Company believes the complaint and allegations to be without merit and intends to vigorously defend itself against these actions. The Company is unable at this time to determine whether the outcome of the litigation would have a material impact on the Company’s financial position, results of operations, or cash flows.
All other legal proceedings are of an ordinary and routine nature and are incidental to our operations. Management believes that such proceedings should not, individually or in the aggregate, have a material adverse effect on our business, financial condition, results of operations, or cash flows. In making that determination, we analyze the facts and circumstances of each case at least quarterly in consultation with our attorneys and determine a range of reasonably possible outcomes.
Note 12. Preferred Stock and Stockholders' Equity
Series D Perpetual Preferred Stock
On March 22, 2021, we completed a private placement of 65 thousand shares of newly designated Series D Perpetual Preferred Stock, with a par value of $0.01 per share (the “Series D Preferred Stock”) at a price of $1,000 per share, together with detachable warrants (the “2021 Warrants”) to purchase up to 1.9 million shares of our common stock at an exercise price of $0.01 per share. The Series D Preferred Stock has a liquidation preference of $1,000 per share and is redeemable at our option in cash, subject to the applicable redemption premium. Series D Preferred Stock shares earn cash dividends at a rate of 10.0% per year, payable quarterly in arrears, accruing whether or not earned or declared. If no cash dividend is paid, then the
14

Table of Contents
liquidation preference per share effective on the dividend date increases by 12.0% per year. On March 22, 2026, the cash dividend rate and in-kind dividend rate increase by 2.5% per year. Cash dividends are required beginning on September 30, 2027.
The Series D Preferred Stock is classified as mezzanine equity, between liabilities and stockholders’ equity, because certain features of the Series D Preferred Stock could require redemption of the Series D Preferred Stock upon a change of control event that is considered not solely within our control. For initial recognition, the Series D Preferred Stock was recognized at a discounted value, net of issuance costs and allocation to warrants and a bifurcated embedded derivative. The aggregate discount is amortized as a deemed dividend through March 22, 2026, which is the date the dividend rate begins to increase by 2.5% per year. Deemed dividends adjust retained earnings (or in the absence of retained earnings, additional paid-in capital).
In accordance with ASC 815-15, Derivatives and Hedging - Embedded Derivatives, certain features of the Series D Preferred Stock were bifurcated and accounted for as derivatives separately. Note 17 discusses the accounting for these features.
As of March 31, 2021, the carrying value of the Series D Preferred Stock shares was $46.9 million which included $0.2 million of accumulated unpaid and deemed dividends. The following table presents the change in the Series D Preferred Stock carrying value during the three months ended March 31, 2021.

| Three Months Ended March 31, 2021
Beginning balance | $ | — |
Proceeds from issuance of shares, net of issuance costs | 61,793 |
Fair value of 2021 Warrants issued | (14,839) |
Recognition of bifurcated embedded derivative | (282) |
Accrual of in-kind dividends | 168 |
Amortization | 18 |
Ending balance | $ | 46,858 |

Net cash proceeds of $61.8 million from the issuance of the Series D Preferred Stock, along with part of the proceeds from the Term Loan Credit Facility, were used to redeem all of the outstanding shares of the Company’s Series B Convertible Preferred Stock (the “Series B Preferred Stock”).
Series B Convertible Preferred Stock
The Series B Preferred Stock had a liquidation preference of $1,000 per share and was redeemable in cash at our option, subject to the applicable redemption premium. Series B Preferred Stock shares earned cumulative dividends at a rate of 10.625% per year, and accrued whether or not earned or declared. The Series B Preferred Stock was recognized at a discounted value, net of issuance costs and allocation to warrants and bifurcated embedded derivatives. The aggregate discount was amortized as a deemed dividend through December 31, 2023, which is the date the holders had a non-contingent conversion option into a variable number of common shares equal to the liquidation preference plus accrued and unpaid dividends. Deemed dividends adjust retained earnings (or in the absence of retained earnings, additional paid-in capital).
At redemption on March 22, 2021, the carrying value of the Series B Preferred Stock shares included $14.3 million of accumulated unpaid and deemed dividends. The following table presents the change in the Series B Preferred Stock carrying value during the three months ended March 31, 2021.

| Three Months Ended March 31, 2021 |  |
Beginning balance | $ | 105,086 |  |  |
Accrual of in-kind dividends | 14,008 |  |  |
Amortization | 335 |  |  |
Redemption | (119,429) |  |  |
Ending balance | $ | — |  |  |

Preferred Share Purchase Rights
On April 15, 2020, our Board of Directors authorized and declared a dividend of one preferred share purchase right for each outstanding share of common stock to shareholders of record on April 27, 2020. The rights expired on March 31, 2021.
15

Table of Contents
Note 13. Revenue from Contracts with Customers
Revenue is recognized when control of the good or service is transferred to the customer either at a point in time or, in limited circumstances, as our services are rendered over time. Revenue is measured as the amount of consideration we expect to receive in exchange for transferring goods or services. The company provides disaggregated revenue by geographical region and customer industry.

|  |  |  | Three Months Ended March 31, 2021
|  |  |  | Mobile Solutions |  | Power Solutions |  | Intersegment Sales Eliminations |  | Total
United States and Puerto Rico |  |  |  | $ | 37,438 |  |  | $ | 39,806 |  |  | $ | (47) |  |  | $ | 77,197 |
China |  |  |  | 14,414 |  |  | 1,506 |  |  | — |  |  | 15,920 |
Brazil |  |  |  | 9,668 |  |  | 192 |  |  | — |  |  | 9,860 |
Mexico |  |  |  | 5,015 |  |  | 3,397 |  |  | — |  |  | 8,412 |
Germany |  |  |  | 1,767 |  |  | 164 |  |  | — |  |  | 1,931 |
Poland |  |  |  | 1,180 |  |  | 4 |  |  | — |  |  | 1,184 |
Other |  |  |  | 8,294 |  |  | 4,006 |  |  | — |  |  | 12,300 |
Total net sales |  |  |  | $ | 77,776 |  |  | $ | 49,075 |  |  | $ | (47) |  |  | $ | 126,804 |

|  |  |  | Three Months Ended March 31, 2020
|  |  |  | Mobile Solutions |  | Power Solutions |  | Intersegment Sales Eliminations |  | Total
United States and Puerto Rico |  |  |  | $ | 37,129 |  |  | $ | 38,297 |  |  | $ | (72) |  |  | $ | 75,354 |
China |  |  |  | 7,692 |  |  | 1,157 |  |  | — |  |  | 8,849 |
Brazil |  |  |  | 8,583 |  |  | 130 |  |  | — |  |  | 8,713 |
Mexico |  |  |  | 4,836 |  |  | 2,143 |  |  | — |  |  | 6,979 |
Germany |  |  |  | 2,150 |  |  | 39 |  |  | — |  |  | 2,189 |
Poland |  |  |  | 1,758 |  |  | 5 |  |  | — |  |  | 1,763 |
Other |  |  |  | 7,736 |  |  | 4,630 |  |  | — |  |  | 12,366 |
Total net sales |  |  |  | $ | 69,884 |  |  | $ | 46,401 |  |  | $ | (72) |  |  | $ | 116,213 |

16

Table of Contents

|  |  |  | Three Months Ended March 31, 2021
|  |  |  | Mobile Solutions |  | Power Solutions |  | Intersegment Sales Eliminations |  | Total
Automotive |  |  |  | $ | 50,144 |  |  | $ | 13,460 |  |  |  |  | $ | 63,604 |
General Industrial |  |  |  | 24,310 |  |  | 13,710 |  |  |  |  | 38,020 |
Electrical |  |  |  | — |  |  | 15,182 |  |  |  |  | 15,182 |
Other |  |  |  | 3,322 |  |  | 6,723 |  |  | (47) |  |  | 9,998 |
Total net sales |  |  |  | $ | 77,776 |  |  | $ | 49,075 |  |  | $ | (47) |  |  | $ | 126,804 |

|  |  |  | Three Months Ended March 31, 2020
|  |  |  | Mobile Solutions |  | Power Solutions |  | Intersegment Sales Eliminations |  | Total
Automotive |  |  |  | $ | 49,074 |  |  | $ | 12,364 |  |  |  |  | $ | 61,438 |
General Industrial |  |  |  | 17,979 |  |  | 12,543 |  |  |  |  | 30,522 |
Electrical |  |  |  | — |  |  | 13,861 |  |  |  |  | 13,861 |
Other |  |  |  | 2,831 |  |  | 7,633 |  |  | (72) |  |  | 10,392 |
Total net sales |  |  |  | $ | 69,884 |  |  | $ | 46,401 |  |  | $ | (72) |  |  | $ | 116,213 |

Transaction Price Allocated to Future Performance Obligations
We are required to disclose the aggregate amount of transaction price that is allocated to performance obligations that have not yet been satisfied as of March 31, 2021, unless our contracts meet one of the practical expedients. Our contracts met the practical expedient for a performance obligation that is part of a contract that has an original expected duration of one year or less.
Sales Concentration
We recognized sales from a single customer of $13.1 million, or 10% of consolidated net sales, during the three months ended March 31, 2021. We recognized sales from another customer of $11.1 million, or 10% of consolidated net sales, during the three months ended March 31, 2020. Revenues from these customers are primarily in our Mobile Solutions segment.
Note 14. Share-Based Compensation
Share-based compensation cost is recognized in the “Selling, general, and administrative expense” line in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) except for $0.2 million, attributable to discontinued operations for the three months ended March 31, 2020. The following table lists the components of share-based compensation expense by type of award.

|  | Three Months Ended March 31, |  |
|  | 2021 |  | 2020 |  |  |  |  |  |
Stock options |  | $ | 89 |  |  | $ | 181 |  |  |  |  |  |  |
Restricted stock |  | 548 |  |  | 892 |  |  |  |  |  |  |
Performance share units |  | 249 |  |  | 223 |  |  |  |  |  |  |
Share-based compensation expense |  | $ | 886 |  |  | $ | 1,296 |  |  |  |  |  |  |

17

Table of Contents
Stock Options
The following table presents stock option activity for the three months ended March 31, 2021.

|  | Number of Options (in thousands) |  | Weighted- Average Exercise Price (per share) |  | Weighted- Average Remaining Contractual Term |  | Aggregate Intrinsic Value |  |
Outstanding at January 1, 2021 |  | 871 |  |  | $ | 12.41 |  |  |  |  |  |  |
Forfeited or expired |  | (24) |  |  | 13.41 |  |  |  |  |  |  |
Outstanding at March 31, 2021 |  | 847 |  |  | $ | 12.38 |  |  | 3.7 years |  | $ | — |  |  | (1)
Exercisable at March 31, 2021 |  | 751 |  |  | $ | 12.83 |  |  | 3.0 years |  | $ | — |  |  | (1)

_______________________________
(1)The aggregate intrinsic value is the sum of intrinsic values for each exercisable individual option grant. The intrinsic value is the amount by which the closing market price of our stock at March 31, 2021, was greater than the exercise price of any individual option grant.
Restricted Stock
During the three months ended March 31, 2021, we granted 425 thousand shares of restricted stock to non-executive directors, officers and certain other key employees. The shares of restricted stock granted during the three months ended March 31, 2021, vest pro-rata generally over three years for employees and over one year for non-executive directors. We determined the fair value of the shares awarded by using the closing price of our common stock as of the date of grant. The weighted average grant date fair value of restricted stock granted in the three months ended March 31, 2021, was $6.79 per share. Total grant date fair value of restricted stock that vested in the three months ended March 31, 2021, was $2.7 million.
The following table presents the status of unvested restricted stock awards as of March 31, 2021, and changes during the three months then ended.

|  | Nonvested Restricted Shares (in thousands) |  | Weighted Average Grant-Date Fair Value (per share)
Unvested at January 1, 2021 |  | 385 |  |  | $ | 9.42 |
Granted |  | 425 |  |  | 6.79 |
Vested |  | (284) |  |  | 9.50 |
Forfeited |  | (12) |  |  | 7.76 |
Unvested at March 31, 2021 |  | 514 |  |  | $ | 7.24 |

Performance Share Units
Performance Share Units (“PSUs”) are a form of long-term incentive compensation awarded to executive officers and certain other key employees designed to directly align the interests of employees to the interests of our stockholders, and to create long-term stockholder value. PSUs granted in 2021 were made pursuant to the NN, Inc. 2019 Omnibus Incentive Plan and a Performance Share Unit Agreement (the “2019 Omnibus Agreement”). Some PSUs are based on total shareholder return (“TSR Awards”), and other PSUs are based on return on invested capital (“ROIC Awards”).
The TSR Awards vest, if at all, upon our achieving a specified relative total shareholder return, which will be measured against the total shareholder return of the S&P SmallCap 600 Index during specified performance periods as defined in the 2019 Omnibus Agreement. The ROIC Awards vest, if at all, upon our achieving a specified average return on invested capital during the performance periods. Each performance period generally begins on January 1 of the year of grant and ends 36 months later on December 31.
We recognize compensation expense over the performance period in which the performance and market conditions are measured. If the PSUs do not vest at the end of the performance periods, then the PSUs will expire automatically. Upon vesting, the PSUs will be settled by the issuance of shares of our common stock, subject to the award recipient’s continued employment. The actual number of shares of common stock to be issued to each award recipient at the end of the performance
18

Table of Contents
periods will be interpolated between a threshold and maximum payout amount based on actual performance results. No dividends will be paid on outstanding PSUs during the performance period; however, dividend equivalents will be paid based on the number of shares of common stock that are ultimately earned at the end of the performance periods.
With respect to the TSR and ROIC Awards, a participant will earn 50% of the target number of PSUs for “Threshold Performance,” 100% of the target number of PSUs for “Target Performance,” and 150% of the target number of PSUs for “Maximum Performance.” For performance levels falling between the values shown below, the percentages will be determined by interpolation.
The following table presents the goals with respect to TSR Awards and ROIC Awards granted or modified in 2021.

TSR Awards: |  | Threshold Performance (50% of Shares) |  | Target Performance (100% of Shares) |  | Maximum Performance (150% of Shares)
2021 grants |  | 35th Percentile |  | 50th Percentile |  | 75th Percentile
ROIC Awards: |  | Threshold Performance (50% of Shares) |  | Target Performance (100% of Shares) |  | Maximum Performance (150% of Shares)
2021 grants |  | 6.3% |  | 7.0% |  | 8.6%
2020 grants (1) |  | 6.7% |  | 7.9% |  | 8.7%

_______________________________
(1)The performance levels for 2020 grants were modified by the compensation committee of the board of directors in the first quarter of 2021 to adjust for the sale of the Life Sciences business and the ongoing effects of the COVID-19 pandemic.
We estimate the grant date fair value of TSR Awards using the Monte Carlo simulation model, as the total shareholder return metric is considered a market condition under ASC Topic 718, Compensation – stock compensation. The grant date fair value of ROIC Awards is based on the closing price of a share of our common stock on the date of grant.
The following table presents the number of PSUs granted and the grant date fair value in the period presented.

|  | TSR Awards |  | ROIC Awards
Award Year |  | Shares (in thousands) |  | Grant Date Fair Value (per share) |  | Shares (in thousands) |  | Grant Date Fair Value (per share)
2021 |  | 142 |  | $8.58 |  | 172 |  | $7.20

We recognize expense for ROIC Awards based on the probable outcome of the associated performance condition. We generally recognize an expense for ROIC Awards based on the Target Performance threshold of 100% because, at the date of grant, the Target Performance is the probable level of performance achievement.
The following table presents the status of unvested PSUs as of March 31, 2021, and changes during the three months then ended.

|  | Nonvested TSR Awards |  | Nonvested ROIC Awards
|  | Shares (in thousands) |  | Weighted Average Grant-Date Fair Value (per share) |  | Shares (in thousands) |  | Weighted Average Grant-Date Fair Value (per share)
Nonvested at January 1, 2021 |  | 138 |  |  | $ | 10.58 |  |  | 160 |  |  | $ | 9.13 |
Granted |  | 142 |  |  | 8.58 |  |  | 172 |  |  | 7.20 |
Nonvested at March 31, 2021 |  | 280 |  |  | $ | 9.56 |  |  | 332 |  |  | $ | 8.13 |

19

Table of Contents
Note 15. Accumulated Other Comprehensive Income
The following tables present the components of accumulated other comprehensive income (“AOCI”).

|  | Foreign Currency Translation |  | Interest rate swap |  | Income taxes (1) |  | Total
Balance at December 31, 2020 |  | $ | (30,881) |  |  | $ | (3,712) |  |  | $ | 861 |  |  | $ | (33,732) |
Other comprehensive income (loss) before reclassifications |  | (3,347) |  |  | — |  |  | — |  |  | (3,347) |
Amounts reclassified from AOCI to loss on interest rate swap (3) |  | — |  |  | 3,712 |  |  | (861) |  |  | 2,851 |
Net other comprehensive income (loss) |  | (3,347) |  |  | 3,712 |  |  | (861) |  |  | (496) |
Balance at March 31, 2021 |  | $ | (34,228) |  |  | $ | — |  |  | $ | — |  |  | $ | (34,228) |
Balance at December 31, 2019 |  | $ | (35,159) |  |  | $ | (12,234) |  |  | $ | 2,839 |  |  | $ | (44,554) |
Other comprehensive income (loss) before reclassifications |  | (14,342) |  |  | (14,599) |  |  | 3,390 |  |  | (25,551) |
Amounts reclassified from AOCI to interest expense (2) |  | — |  |  | 1,370 |  |  | (318) |  |  | 1,052 |
Net other comprehensive income (loss) |  | (14,342) |  |  | (13,229) |  |  | 3,072 |  |  | (24,499) |
Balance at March 31, 2020 |  | $ | (49,501) |  |  | $ | (25,463) |  |  | $ | 5,911 |  |  | $ | (69,053) |

_______________________
(1) Income tax effect of changes in interest rate swap.
(2) Represents settlements on the interest rate swap while the hedge was effective.
(3) Represents reclassification of derivative loss and settlements after discontinuation of hedge accounting.
Note 16. Net Income (Loss) Per Common Share
In accordance with ASC 260, Earnings Per Share, a company that has participating securities is required to utilize the two-class method for calculating earnings per share (“EPS”) unless the treasury stock method results in lower EPS. The two-class method is an allocation of earnings between the holders of common stock and a company’s participating securities. Basic EPS is calculated by dividing income or loss attributable to common stockholders by the weighted average number of shares of common stock outstanding. To calculate diluted EPS, basic EPS is further adjusted to include the effect of potentially dilutive stock options, warrants, and convertible preferred stock.
20

Table of Contents
The following table summarizes the computation of basic and diluted net loss per common share.

|  | Three Months Ended March 31, |  |
|  | 2021 |  | 2020 |  |  |  |  |  |
Numerator: |  |  |  |  |  |  |  |  |  |
Loss from continuing operations |  | $ | (4,913) |  |  | $ | (108,077) |  |  |  |  |  |  |
Less: Preferred stock cumulative dividends and deemed dividends |  | (14,529) |  |  | (2,951) |  |  |  |  |  |  |
Numerator for basic and diluted loss from continuing operations per common share (1) |  | (19,442) |  |  | (111,028) |  |  |  |  |  |  |
Loss from discontinued operations, net of tax (Note 2) |  | — |  |  | (140,114) |  |  |  |  |  |  |
Numerator for basic and diluted undistributed net loss per common share (1) |  | $ | (19,442) |  |  | $ | (251,142) |  |  |  |  |  |  |
Denominator: |  |  |  |  |  |  |  |  |  |
Weighted average common shares outstanding, basic and diluted |  | 42,461 |  |  | 42,111 |  |  |  |  |  |  |
Weighted average warrants outstanding, basic and diluted (2) |  | 211 |  |  | — |  |  |  |  |  |  |
Shares used to calculate income (loss) per share, basic and diluted |  | 42,672 |  |  | 42,111 |  |  |  |  |  |  |
Per common share net loss: |  |  |  |  |  |  |  |  |  |
Basic loss from continuing operations per common share |  | $ | (0.46) |  |  | $ | (2.64) |  |  |  |  |  |  |
Basic loss from discontinued operations per common share |  | — |  |  | (3.32) |  |  |  |  |  |  |
Basic net loss per common share |  | $ | (0.46) |  |  | $ | (5.96) |  |  |  |  |  |  |
Diluted loss from continuing operations per common share |  | $ | (0.46) |  |  | $ | (2.64) |  |  |  |  |  |  |
Diluted loss from discontinued operations per common share |  | — |  |  | (3.32) |  |  |  |  |  |  |
Diluted net loss per common share |  | $ | (0.46) |  |  | $ | (5.96) |  |  |  |  |  |  |
Cash dividends declared per common share |  | $ | — |  |  | $ | — |  |  |  |  |  |  |

_______________________________
(1) Preferred Stock does not participate in losses.
(2) The 2021 Warrants are included in shares outstanding for calculation of basic earnings per share because they are exercisable with little to no consideration (see Note 17).
The following table presents securities that could be potentially dilutive in the future that were excluded from the calculation of diluted net loss per common share because they had an anti-dilutive effect.

|  | Three Months Ended March 31, |  |
|  | 2021 |  | 2020 |  |  |  |
Options |  | 847 |  |  | 897 |  |  |  |  |
2019 Warrants |  | 1,500 |  |  | 1,500 |  |  |  |  |
Preferred Stock, as-converted |  | — |  |  | 26,275 |  |  |  |  |
|  | 2,347 |  |  | 28,672 |  |  |  |  |

We have elected to allocate undistributed income to participating securities based on year-to-date results. As there was no undistributed income for the three months ended March 31, 2021, no such allocation was necessary. In addition, given the undistributed loss from continuing operations in the three months ended March 31, 2021 and 2020, options and the 2019 Warrants are considered anti-dilutive and were excluded from the calculation of diluted net income (loss) per share. Stock options excluded from the calculations of diluted net loss per share had a per share exercise price ranging from $7.93 to $25.16 for the three months ended March 31, 2021, and $7.93 to $25.16 for three months ended March 31, 2020. Warrants excluded from the calculation of diluted net loss per share for the three months ended March 31, 2021, had a per share exercise price of $11.49. Preferred Stock excluded from the calculation of diluted net loss per share for the three months ended March 31, 2020, was calculated on an as-converted basis.
21

Table of Contents
Note 17. Fair Value Measurements
Fair value is an exit price representing the expected amount that an entity would receive to sell an asset or pay to transfer a liability in an orderly transaction with market participants at the measurement date. We followed consistent methods and assumptions to estimate fair values as more fully described in the 2020 Annual Report.
Fair value principles prioritize valuation inputs across three broad levels. Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities. Level 2 inputs are quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the financial instrument. Level 3 inputs are unobservable inputs based on the assumptions used to measure assets and liabilities at fair value. An asset or liability’s classification within the various levels is determined based on the lowest level input that is significant to the fair value measurement.
Our financial instruments that are subject to fair value disclosure consist of cash and cash equivalents, accounts receivable, accounts payable, derivatives, and long-term debt. As of March 31, 2021, the carrying values of these financial instruments approximated fair value.
Derivative Financial Instruments
Certain features were bifurcated and accounted for separately from the Series B Preferred Stock. The following features were recorded as derivatives.
•Leverage ratio put feature. The Series B Preferred Stock included a redemption option based on a leverage ratio threshold that provided the preferred holder the option to convert the Series B Preferred Stock to a variable number of shares of common stock at a discount to the then fair value of our common stock. The conversion feature was considered a redemption right at a premium which was not clearly and closely related to the debt host. The conversion feature was terminated upon redemption of the Series B Preferred Stock in March 2021.
•Dividends withholding. The Series B Preferred Stock bore a feature that could require us to make an effective distribution to purchasers which is indexed to the tax rate of the purchasers. This distribution would be partially offset by an adjustment to the redemption price and/or conversion rate. The dividends withholding feature was not clearly and closely related to the debt host. Upon redemption of the Series B Preferred Stock in March 2021, we made a net cash distribution of $3.0 million to settle this withholding feature after effectively receiving a $1.0 million offset from the purchasers upon redemption of the Series B Preferred Stock.
•Warrants. The warrants issued with the Series B Preferred Stock (the “2019 Warrants”) are exercisable, in full or in part, at any time prior to December 11, 2026. The original exercise price was $12.00 per share, subject to anti-dilution adjustments in the event of future below market issuances, stock splits, stock dividends, combinations or similar events. The issuance of additional warrants with the Series D Preferred Stock in March 2021 resulted in an adjusted exercise price of $11.49 per share because the new warrants have an exercise price below market value.
Certain features were bifurcated and accounted for separately from the Series D Preferred Stock that was issued on March 22, 2021. The following features were recorded as derivatives.
•Change-in-control put feature. The Series D Preferred Stock includes a put feature that allows the holder to redeem the Series D Preferred Stock upon a change in control at the greater of 1) the liquidation preference plus accrued dividends or 2) 140% of the liquidation preference. The put feature is considered a redemption right at a premium and is not clearly and closely related to the debt host.
•Warrants. The warrants issued with the Series D Preferred Stock (the “2021 Warrants”) are exercisable, in full or in part, at any time prior to March 22, 2027, at an exercise price of $0.01 per share, subject to anti-dilution adjustments in the event of certain future equity issuances, stock splits, stock dividends, combinations or similar events.
The following tables show the liabilities measured at fair value for the above derivatives as of March 31, 2021, and December 31, 2020.

|  | Fair Value Measurements as of March 31, 2021
Description |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Derivative liability - other current liabilities |  | $ | — |  |  | $ | — |  |  | $ | — |
Derivative liability - other non-current liabilities |  | 13,414 |  |  | — |  |  | 1,370 |
Total |  | $ | 13,414 |  |  | $ | — |  |  | $ | 1,370 |

22

Table of Contents

|  | Fair Value Measurements as of December 31, 2020
Description |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Derivative liability - other current liabilities |  | $ | — |  |  | $ | — |  |  | $ | 2,453 |
Derivative liability - other non-current liabilities |  | — |  |  | — |  |  | 664 |
Total |  | $ | — |  |  | $ | — |  |  | $ | 3,117 |

The following table presents the change in the above derivatives during the three months ended March 31, 2021.

|  | Three Months Ended March 31, 2021
Beginning balance |  | $ | 3,117 |
Issuances |  | 15,121 |
Change in fair value (1) |  | (449) |
Settlements |  | (3,005) |
Ending balance |  | $ | 14,784 |

_______________________________
(1) Changes in the fair value are recognized in the “Other expense (income), net” line in the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).
The fair value of the change-in-control put feature utilizes unobservable inputs based on the Company’s assessment of the probability of a change-in-control event occurring in a future period. The probability of a change-in-control event ranged from 1% to 10% as of March 31, 2021.
The leverage ratio put feature, the dividends withholding feature, and the contingent dividends feature utilized unobservable inputs based on the best information available to determine the probability of the Series B Preferred Stock remaining outstanding for future periods. These inputs included probability assessments of how long the preferred stock would remain outstanding and whether the leverage ratio threshold would be exceeded. Inputs also included the percentage of Series B Preferred Stock held by non-U.S. resident holders and the applicable tax withholding rates for those holders. The probability of the Series B Preferred Stock remaining in future periods ranged from 3% to 2% as of December 31, 2020. The leverage ratio put feature also utilized unobservable inputs to determine the probability of the leverage ratio put being exercisable as of March 31, 2023, which ranged from 10% to 1% as of December 31, 2020. These probabilities were determined based on management’s assessment of facts and circumstances at each reporting date. An increase in these probabilities would result in an increase in the derivative liability fair value. Given the Series B Preferred Stock value changes by period as a result of dividends and redemption premiums, weighted average values for these assumptions are not meaningful.
The fair value of the 2019 Warrants is determined using a valuation model, which utilizes unobservable inputs to determine the probability that the 2019 Warrants will remain outstanding for future periods. The probabilities resulted in a weighted average term of 4.3 years as of March 31, 2021, and 2.4 years as of December 31, 2020.
The fair value of the 2021 Warrants is determined using the observable market price of a share of our common stock, less the $0.01 per share exercise price.
Interest Rate Swap
We manage our exposure to fluctuations in interest rates using a mix of fixed and variable rate debt. We had a fixed-rate interest rate swap agreement that changed the LIBOR-based portion of the interest rate on a portion of our variable rate debt to a fixed rate of 2.4575% (the “interest rate swap”). On March 22, 2021, we terminated the interest rate swap agreement with a $13.7 million cash payment in connection with the extinguishment of our previously outstanding long-term variable-rate debt.
The interest rate swap was designated as a cash flow hedge at inception. However, in the fourth quarter of 2020, the interest rate swap no longer qualified as an effective hedge, and subsequent changes in fair value of the interest rate swap were recognized in earnings. Amounts recognized in earnings related to the interest rate swap are recorded in the “Loss on interest rate swap” line on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) except that cash settlements prior to termination are recognized in “Derivative payments on interest rate swap.” Cash settlements during 2021 are presented in investing activities on the Condensed Consolidated Statements of Cash Flows. The following table presents
23

Table of Contents
the effect of the interest rate swap on the Condensed Consolidated Statements of Operations and Comprehensive Income (Loss).

|  | Three Months Ended March 31,
|  | 2021 |  | 2020
Interest expense |  | $ | — |  |  | $ | 1,370 |
Derivative payments on interest rate swap |  | 1,717 |  |  | — |
Loss on interest rate swap |  | 2,033 |  |  | — |

The following table presents the liabilities measured at fair value on a recurring basis for the interest rate swap as of December 31, 2020.

|  | Fair Value Measurements as of December 31, 2020
Description |  | Quoted Prices in Active Markets for Identical Assets (Level 1) |  | Significant Other Observable Inputs (Level 2) |  | Significant Unobservable Inputs (Level 3)
Derivative liability - other current liabilities |  | $ | — |  |  | $ | 11,022 |  |  | $ | — |
Derivative liability - other non-current liabilities |  | — |  |  | 4,357 |  |  | — |
Total |  | $ | — |  |  | $ | 15,379 |  |  | $ | — |

The inputs for determining fair value of the interest rate swap are classified as Level 2 inputs. Level 2 fair value is based on estimates using standard pricing models. These standard pricing models use inputs which are derived from or corroborated by observable market data such as interest rate yield curves, index forward curves, discount curves, and volatility surfaces. Counterparty to this derivative contract is a highly rated financial institution which we believe carries only a minimal risk of nonperformance.
Fixed Rate Debt
The fair value of our outstanding fixed-rate debt included in the “International lines of credit and other loans” line item within Note 9 to these Notes to Condensed Consolidated Financial Statements approximated carrying value as of March 31, 2021, and December 31, 2020, respectively. These fair values represent Level 2 under the three-tier hierarchy described above. The carrying value of this fixed-rate debt was $12.5 million and $14.4 million as of March 31, 2021 and December 31, 2020, respectively.
24

Table of Contents
Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations
Overview
NN, Inc. is a global diversified industrial company that combines advanced engineering and production capabilities with in-depth materials science expertise to design and manufacture high-precision components and assemblies primarily for the electrical, automotive, general industrial, aerospace and defense, and medical markets. As used in this Quarterly Report, the terms “NN,” the “Company,” “we,” “our,” or “us” refer to NN, Inc. and its subsidiaries.
Forward-Looking Statements
This Quarterly Report contains forward-looking statements that are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements may discuss goals, intentions and expectations as to future trends, plans, events, results of operations or financial condition, or state other information relating to NN, Inc., based on current beliefs of management as well as assumptions made by, and information currently available to, management. Forward-looking statements generally will be accompanied by words such as “anticipate,” “believe,” “could,” “estimate,” “expect,” “forecast,” “guidance,” “intend,” “may,” “possible,” “potential,” “predict,” “project” or other similar words, phrases or expressions. Forward-looking statements involve a number of risks and uncertainties that are outside of management’s control and that may cause actual results to be materially different from such forward-looking statements. Such factors include, among others, general economic conditions and economic conditions in the industrial sector; the impacts of the COVID-19 pandemic on the Company’s financial condition, business operations and liquidity; competitive influences; risks that current customers will commence or increase captive production; risks of capacity underutilization; quality issues; availability of raw materials; currency and other risks associated with international trade; our dependence on certain major customers; the impact of acquisitions and divestitures; the level of our indebtedness; the restrictions contained in our debt agreements; our ability to obtain financing at favorable rates, if at all, and to refinance existing debt as it matures; unanticipated difficulties integrating acquisitions; new laws and governmental regulations; and other risk factors and cautionary statements listed from time-to-time in our periodic reports filed with the Securities and Exchange Commission. We disclaim any obligation to update any such factors or to publicly announce the result of any revisions to any of the forward-looking statements included herein or therein to reflect future events or developments.
For additional information concerning such risk factors and cautionary statements, please see the sections titled “Item 1A. Risk Factors” in the 2020 Annual Report and this Quarterly Report.
Results of Operations
Factors That May Influence Results of Operations
The following paragraphs describe factors that have influenced results of operations for the three months ended March 31, 2021, that management believes are important to provide an understanding of the business and results of operations or that may influence operations in the future.
Global COVID-19 Pandemic
The COVID-19 pandemic continues to disrupt the United States and global economy, and we cannot predict when a full economic recovery will occur, but product volumes are beginning to return to more normalized levels. Our operating results in the first quarter reflect momentum in the recovery of our business from the effects of COVID-19. Although vaccinations are in process and economies across the globe have reopened, many public health experts warn there may be additional COVID-19 surges in 2021. Further surges in the COVID-19 infection rates could result in the reinstatement of directives and mandates requiring businesses to again curtail or cease normal operations. Thus, the spread of COVID-19 and the responses thereto have created a disruption in the manufacturing, delivery, and overall supply chain of automobile manufacturers and suppliers, as well as disruption within the power industry. Global vehicle production decreased significantly in 2020, but production has since been ramping back up. Disruptions of normal supply chains have caused challenges in obtaining raw materials we use in the manufacture of some of our products. We have been increasing our inventories in the first quarter to mitigate the risk of supply chain disruption for our customers. A worldwide semiconductor chip shortage is beginning to affect original equipment manufacturers, causing unpredictable volumes. The rapid development and fluidity of the situation precludes any prediction as to the ultimate impact COVID-19 will have on our business, financial condition, results of operations, and cash flows, which will depend largely on future developments directly or indirectly relating to the duration and scope of the COVID-19 pandemic.
While managing decreased demand in many regions across the globe, we are now operating at all of our business locations. We have implemented training and recruiting programs to address labor shortages. We are focused on the safety of our employees, customers and suppliers. We have developed and implemented processes to ensure a safe environment for our employees and
25

Table of Contents
any visitors to our facilities, including providing personal protective equipment to our employees and establishing social distancing protocols and temperature checks. We are actively promoting vaccination among our employees. These processes include recommendations based on guidelines from the Centers for Disease Control and Prevention and the World Health Organization. The health and safety of our employees remains our top priority.
We have undertaken a number of permanent and temporary actions to manage the evolving situation, as described in our 2020 Annual Report.. We continue to streamline facilities and implement cost savings initiatives. Capital expenditures and travel costs remain at relatively low levels. We refinanced our credit facility and preferred stock in the first quarter as discussed above.
Credit Facilities
On March 22, 2021, we entered into a new $150.0 million term loan facility (the “Term Loan Facility”) and a new $50.0 million asset backed credit facility (the “ABL Facility”). The proceeds from the Term Loan Facility were used to prepay the amounts outstanding on our previous term loans. The previous credit facility was terminated and consisted of a Senior Secured Term Loan, Incremental Term Loan, and Senior Secured Revolver. No amounts were outstanding on the Senior Secured Revolver at the time of termination.
Outstanding borrowings under the Term Loan Facility bear interest at either 1) one-month LIBOR (subject to a 1.000% floor) plus an applicable margin of 6.875% or 2) the greater of various benchmark rates plus an applicable margin of 5.875%. At March 31, 2021, the Term Loan Facility bore interest based on one-month LIBOR at 7.875%. The Term Loan Facility requires quarterly principal payments of $0.4 million with the remaining unpaid principal amount due on the final maturity date of September 22, 2026. The Term Loan Facility is collateralized by all of our assets. The Term Loan Facility has a first lien on all assets other than accounts receivable and inventory and has a second lien on accounts receivable and inventory. We were in compliance with all requirements under the Term Loan Facility as of March 31, 2021.
The ABL Facility provides for a senior secured revolving credit facility in the amount of $50.0 million, of which $30.0 million is available in the form of letters of credit and $5.0 million is available for the issuance of short-term swingline loans. The availability of credit under the ABL Facility is limited by a borrowing base calculation derived from accounts receivable and inventory held in the United States. Outstanding borrowings under the ABL Facility bear interest on a variable rate structure plus an interest rate spread that is based on the average amount of aggregate revolving commitment available. The variable borrowing rate is either 1) LIBOR plus an applicable margin of 1.75% or 2.00%, depending on availability, or 2) the greater of the federal funds rate or prime, plus an applicable margin of 0.75% or 1.00%, depending on availability. We may elect whether to use one-month, three-month, or six-month LIBOR, subject to a 0.50% floor. Interest payments are due monthly on borrowings that utilize one-month LIBOR and quarterly on borrowings that utilize three-month or six-month LIBOR. At March 31, 2021, using one-month LIBOR plus a 1.75% spread, the weighted average interest rate on outstanding borrowings under the ABL Facility would have been 2.25% if there had been any balance outstanding. We pay a commitment fee of 0.375% for unused capacity under the ABL Facility and a 0.125% fee on the amount of letters of credit outstanding. The final maturity date of the ABL Facility is March 22, 2026.
We had no outstanding borrowings under the ABL Facility at March 31, 2021. Total capacity under the ABL Facility was $47.3 million as of March 31, 2021, with $32.9 million available for future borrowings after reductions for outstanding letters of credit as of March 31, 2021. The ABL Facility has a first lien on accounts receivable and inventory. We were in compliance with all requirements under the ABL Facility as of March 31, 2021.
Preferred Stock
On March 22, 2021, we completed a private placement of 65 thousand shares of newly designated Series D Perpetual Preferred Stock, with a par value of $0.01 per share (the “Series D Preferred Stock”) at a price of $1,000 per share, together with detachable warrants (the “2021 Warrants”) to purchase up to 1.9 million shares of our common stock at an exercise price of $0.01 per share. The Series D Preferred Stock has a liquidation preference of $1,000 per share and is redeemable at our option in cash, subject to the applicable redemption premium. Series D Preferred Stock shares earn cash dividends at a rate of 10.0% per year, payable quarterly in arrears, accruing whether or not earned or declared. If no cash dividend is paid, then the liquidation preference per share effective on the dividend date increases by 12.0% per year. On March 22, 2026, the cash dividend rate and in-kind dividend rate increase by 2.5% per year. Cash dividends are required beginning on September 30, 2027.
Net cash proceeds of $61.8 million from the issuance of the Series D Preferred Stock, along with part of the proceeds from the Term Loan Credit Facility, were used to redeem all of the outstanding shares of the Company’s Series B Convertible Preferred Stock (the “Series B Preferred Stock”). The total redemption cash payment was $118.4 million.
26

Table of Contents
Sales Concentration
We recognized sales from a single customer of $13.1 million, or 10% of consolidated net sales, during the three months ended March 31, 2021. We recognized sales from another customer of $11.1 million, or 10% of consolidated net sales, during the three months ended March 31, 2020. Revenues from these customers are primarily in our Mobile Solutions segment.
Three Months Ended March 31, 2021, compared to the Three Months Ended March 31, 2020

|  | Three Months Ended March 31,
|  | 2021 |  | 2020 |  | $ Change
Net sales |  | $ | 126,804 |  |  | $ | 116,213 |  |  | $ | 10,591 |  |
Organic growth |  |  |  |  |  |  | $ | 11,248 |
Foreign exchange effects |  |  |  |  |  |  | (657) |
Cost of sales (exclusive of depreciation and amortization shown separately below) |  | 99,688 |  |  | 94,478 |  |  | 5,210 |  |
Selling, general, and administrative expense |  | 14,575 |  |  | 16,160 |  |  | (1,585) |  |
Depreciation and amortization |  | 11,568 |  |  | 11,357 |  |  | 211 |  |
Goodwill impairment |  | — |  |  | 92,942 |  |  | (92,942) |  |
Other operating expense (income), net |  | (5) |  |  | 5,126 |  |  | (5,131) |  |
Income (loss) from operations |  | 978 |  |  | (103,850) |  |  | 104,828 |  |
Interest expense |  | 2,024 |  |  | 3,807 |  |  | (1,783) |  |
Loss on extinguishment of debt and write-off of debt issuance costs |  | 2,390 |  |  | — |  |  | 2,390 |  |
Derivative payments on interest rate swap |  | 1,717 |  |  | — |  |  | 1,717 |  |
Loss on interest rate swap |  | 2,033 |  |  | — |  |  | 2,033 |  |
Other expense (income), net |  | (122) |  |  | 1,544 |  |  | (1,666) |  |
Loss from continuing operations before benefit for income taxes and share of net income (loss) from joint venture |  | (7,064) |  |  | (109,201) |  |  | 102,137 |  |
Benefit for income taxes |  | 756 |  |  | 1,395 |  |  | (639) |  |
Share of net income (loss) from joint venture |  | 1,395 |  |  | (271) |  |  | 1,666 |  |
Loss from continuing operations |  | (4,913) |  |  | (108,077) |  |  | 103,164 |  |
Income (loss) from discontinued operations, net of tax |  | — |  |  | (140,114) |  |  | 140,114 |  |
Net loss |  | $ | (4,913) |  |  | $ | (248,191) |  |  | $ | 243,278 |  |

Net Sales. Net sales increased by $10.6 million, or 9%, during the three months ended March 31, 2021, compared to the three months ended March 31, 2020, primarily due to an increase in organic volume of $11.2 million, as a result of increased demand in the automotive industry as the economy begins to recover from the impact of the COVID-19 pandemic. Sales were positively impacted by increased selling prices for precious metals allowed under customer contracts due to the sharp rise in underlying commodities costs since the second half of 2020. These increases were partially offset by decreased demand for smart meter components due to inventory adjustments at a key customer. Sales of components to the medical industry were also negatively impacted by delays in elective surgeries caused by the COVID-19 pandemic. We also realized unfavorable foreign exchange effects of $0.7 million.
Cost of Sales. Cost of sales increased by $5.2 million, or 6%, during the three months ended March 31, 2021, compared to the three months ended March 31, 2020, primarily due to variable costs associated with the above-referenced sales volume increase, partially offset by variable and fixed cost reduction initiatives.
Selling, General and Administrative Expense. Selling, general and administrative expense decreased by $1.6 million during the three months ended March 31, 2021, compared to the three months ended March 31, 2020, primarily due to cost reduction initiatives that drove decreases in personnel and travel costs.
Goodwill Impairment. We recognized goodwill impairment of $92.9 million at Power Solutions during the three months ended March 31, 2020, which resulted in no remaining goodwill balance.
Other Operating Expense (Income), Net. Other operating expense (income), net, changed favorably by $5.1 million primarily due to charges and costs associated with asset disposals and elimination of a portion of lease obligations as a result of vacating a portion of our corporate headquarters building during the three months ended March 31, 2020.
27

Table of Contents
Interest Expense. Interest expense decreased by $1.8 million during the three months ended March 31, 2021, compared to the three months ended March 31, 2020, primarily due to settlements on the interest rate swap in the prior year that were recognized in interest expense while the hedge was effective. Commitment fees on our Senior Secured Revolver decreased due to a lower available capacity after the sale of our Life Sciences business in October 2020.

|  | Three Months Ended March 31,
|  | 2021 |  | 2020
Interest on debt |  | $ | 1,439 |  |  | $ | 1,851 |
Interest rate swap settlements |  | — |  |  | 1,370 |
Amortization of debt issuance costs |  | 405 |  |  | 426 |
Capitalized interest |  | (31) |  |  | (89) |
Other |  | 211 |  |  | 249 |
Total interest expense |  | $ | 2,024 |  |  | $ | 3,807 |

Loss on Extinguishment of Debt and Write-off of Debt Issuance Costs. Loss on extinguishment of debt and write-off of debt issuance costs represents unamortized debt issuance costs that were associated with the credit facility that was terminated in March 2021.
Derivative Payments on Interest Rate Swap. Derivative payments on interest rate swap represent cash settlements of the interest rate swap after hedge accounting was discontinued in October 2020. Prior to October 2020, interest rate swap settlements were recognized in interest expense.
Loss on Interest Rate Swap. Loss on interest rate swap represents mark-to-market adjustments on the interest rate swap after hedge accounting was discontinued in October 2020 as well as amortization of the residual loss in accumulated other comprehensive income as monthly settlements occur. Prior to October 2020, mark-to-market adjustments on the interest rate swap were recognized in accumulated other comprehensive income. Upon termination of the interest rate swap in March 2021, we recognized in earnings the remaining $3.3 million loss that had been deferred in accumulated other comprehensive income.
Benefit For Income Taxes. Our effective tax rate was 10.7% for the three months ended March 31, 2021, compared to 1.3% for the three months ended March 31, 2020. The difference in rates is primarily due to the impact of the impairment of nondeductible goodwill in 2020, and the estimated impacts of GILTI and the CARES Act. Note 8 in the Notes to Condensed Consolidated Financial Statements describes the effective income tax rate for each period presented.
Share of Net Income from Joint Venture. Our share of net income from the joint venture increased during the three months ended March 31, 2021, compared to the three months ended March 31, 2020, primarily due to improved profits resulting from higher sales volumes, expanding variable margins as a result of successful process improvement initiatives and improved product mix, and fixed cost reduction actions.
Results by Segment
MOBILE SOLUTIONS

|  | Three Months Ended March 31,
|  | 2021 |  | 2020 |  | $ Change
Net sales |  | $ | 77,776 |  |  | $ | 69,884 |  |  | $ | 7,892 |  |
Organic growth |  |  |  |  |  |  | $ | 8,576 |
Foreign exchange effects |  |  |  |  |  |  | (684) |
Income from operations |  | $ | 6,090 |  |  | $ | 264 |  |  | $ | 5,826 |  |

Net sales increased by $7.9 million during the three months ended March 31, 2021, compared to the three months ended March 31, 2020, primarily due to higher demand within all markets which were negatively impacted by the COVID-19 pandemic in the prior year and new business in the general industrial market. The increase in volume was partially offset by unfavorable foreign exchange effects of $0.7 million.
Income from operations increased by $5.8 million during the three months ended March 31, 2021, compared to the same period in the prior year primarily due to the above-noted increase in revenue and variable and fixed cost reduction initiatives. Moreover, we built inventory in the three months ended March 31, 2021, which resulted in favorable overhead absorption during the quarter.
28

Table of Contents
POWER SOLUTIONS

|  | Three Months Ended March 31,
|  | 2021 |  | 2020 |  | $ Change
Net sales |  | $ | 49,075 |  |  | $ | 46,401 |  |  | $ | 2,674 |  |
Organic growth |  |  |  |  |  |  | $ | 2,647 |
Foreign exchange effects |  |  |  |  |  |  | 27 |
Goodwill impairment |  | $ | — |  |  | $ | (92,942) |  |  | $ | 92,942 |  |
Income (loss) from operations |  | $ | 2,432 |  |  | $ | (90,334) |  |  | $ | 92,766 |  |

Net sales increased by $2.7 million during the three months ended March 31, 2021, compared to the three months ended March 31, 2020. Sales were positively impacted by increased selling prices for precious metals allowed under customer contracts due to the sharp rise in underlying commodities costs since the second half of 2020. Furthermore, demand in the automotive market rebounded to more normalized levels after COVID-19. These increases were partially offset by decreased demand for smart meter components due to inventory adjustments at a key customer. Sales of components to the medical industry were also negatively impacted by delays in elective surgeries caused by the COVID-19 pandemic. The Power Solutions group generally began experiencing the impact of the COVID-19 pandemic on its operating results during the second quarter of 2020.
Income from operations increased by $92.8 million compared to the same period in the prior year primarily due to the $92.9 million goodwill impairment lost recognized in the first quarter of 2020. Because increased pricing for precious metals was offset by equivalent increased raw materials cost based on commodity pricing, the increase in sales did not have a proportionate effect on income from operations.
Changes in Financial Condition from December 31, 2020, to March 31, 2021
Overview
From December 31, 2020, to March 31, 2021, total assets decreased by $2.6 million primarily due to normal depreciation and amortization of fixed assets, lease right-of-use assets, and intangible assets. These decreases were offset by increases in accounts receivable and inventories during the three months ended March 31, 2021. Accounts receivable increased as a result of increasing sales, and inventories increased as a result of a strategic decision to mitigate potential supply chain issues for our customers.
From December 31, 2020, to March 31, 2021, total liabilities increased by $75.0 million, primarily due to the refinancing of our credit facilities and Series B Preferred Stock.
Working capital, which consists of current assets less current liabilities, was $124.4 million as of March 31, 2021, compared to $112.0 million as of December 31, 2020. The increase in working capital was primarily due to the increases in accounts receivable and inventories discussed above.
Cash Flows
Cash provided by operations was $7.9 million for the three months ended March 31, 2021, compared with cash provided by operations of $10.2 million for the three months ended March 31, 2020. The difference was primarily due to building inventory levels during the three months ended March 31, 2021, to mitigate potential supply chain issues for our customers.
Cash used in investing activities was $20.9 million for the three months ended March 31, 2021, compared with cash used in investing activities of $11.2 million for the three months ended March 31, 2020. The decrease was primarily due to cash settlement of the interest rate swap, partially offset by lower capital expenditures in the current year.
Cash provided by financing activities was $9.6 million for the three months ended March 31, 2021, compared with cash provided by financing activities of $53.9 million for the three months ended March 31, 2020. The difference was primarily due to $11.9 million net inflow from the debt and preferred stock refinancing in the current year compared to the $60.0 million draw on the Senior Secured Revolver in the prior year.
29

Table of Contents
Liquidity and Capital Resources
Credit Facilities
The principal amount outstanding under our Term Loan Facility as of March 31, 2021, was $150.0 million, without regard to unamortized debt issuance costs. As of March 31, 2021, we had unused borrowing capacity of $32.9 million under the ABL Facility, subject to certain limitations. This amount of borrowing capacity is net of $14.5 million of outstanding letters of credit at March 31, 2021, which are considered as usage of the ABL Facility.
The Term Loan Facility requires quarterly principal payments of $0.4 million with the remaining unpaid principal amount due on the final maturity date of September 22, 2026. If one-month LIBOR is less than 1.00%, then we pay 7.875% per annum in interest. If one-month LIBOR exceeds 1.000%, then we pay the variable one-month LIBOR plus an applicable margin of 6.875%. Based on the interest rate in effect at March 31, 2021, annual interest payments would be approximately $11.8 million.
The ABL Facility bears interest on a variable rate structure with borrowings bearing interest at one-month LIBOR plus an applicable margin of 1.75%. The interest rate in effect at March 31, 2021, was 2.25%. We pay a commitment fee of 0.375% for unused capacity under the ABL Facility.
We were in compliance as of March 31, 2021, with all requirements under our Term Loan Facility and ABL Facility. Both credit facilities allow for optional expansion of available borrowings, subject to certain terms and conditions.
Seasonality and Fluctuation in Quarterly Results
General economic conditions impact our business and financial results, and certain businesses experience seasonal and other trends related to the industries and end markets that they serve. For example, European sales are often weaker in the summer months as customers slow production and sales to original equipment manufacturers are often stronger immediately preceding and following the launch of new products. However, as a whole, we are not materially impacted by seasonality.
Off-Balance Sheet Arrangements
We are not a party to any off-balance sheet arrangements that have, or are reasonably likely to have, a material current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures, or capital resources.
Critical Accounting Policies
Our critical accounting policies, including the assumptions and judgments underlying them, are disclosed in the 2020 Annual Report, including those policies as discussed in Note 1 to the Notes to Consolidated Financial Statements included in the 2020 Annual Report. There have been no changes to these policies during the three months ended March 31, 2021, except as discussed in Note 1 to the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report.
Recent Accounting Pronouncements
See Note 1 in the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report.
Item 3.Quantitative and Qualitative Disclosures About Market Risk
We are exposed to changes in financial market conditions in the normal course of business due to use of certain financial instruments as well as transacting business in various foreign currencies. To mitigate the exposure to these market risks, we have established policies, procedures, and internal processes governing the management of financial market risks. We are exposed to changes in interest rates primarily as a result of borrowing activities.
Interest Rate Risk
Our policy is to manage interest expense using a mixture of fixed and variable rate debt. To manage this mixture of fixed and variable rate debt effectively and mitigate interest rate risk, we may use interest rate swap agreements. The nature and amount of borrowings may vary as a result of future business requirements, market conditions, and other factors.
In February 2019, we entered into a fixed-rate interest rate swap agreement that changed the LIBOR-based portion of the interest rate on a portion of our variable rate debt to a fixed rate of 2.4575%. On March 22, 2021, we terminated the interest rate swap agreement in connection with the prepayment of our previously outstanding long-term variable-rate debt. Refer to
30

Table of Contents
Note 17 in the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report for further discussion about the interest rate swap.
At March 31, 2021, we had $150.0 million of principal outstanding under the Term Loan Facility without regard to capitalized debt issuance costs. A one-percent increase in one-month LIBOR would result in a net increase in interest expense of $0.2 million on an annualized basis due to the fact that the Term Loan Facility is subject to a LIBOR floor of 1.00% and one-month LIBOR was below the floor as of March 31, 2021.
We had no outstanding borrowings under the ABL Facility at March 31, 2021.
Foreign Currency Risk
Translation of our operating cash flows denominated in foreign currencies is impacted by changes in foreign exchange rates. We participate in various third party and intercompany loans, payables, and receivables denominated in currencies other than the U.S. dollar. To help reduce exposure to foreign currency fluctuation, we have incurred debt in euros in the past. From time to time, we may use foreign currency derivatives to hedge currency exposures when these exposures meet certain discretionary levels. We did not hold a position in any foreign currency derivatives as of March 31, 2021.
Item 4.Controls and Procedures
Disclosure Controls and Procedures
Under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, we evaluated the effectiveness of disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were effective as of March 31, 2021, to ensure that information required to be disclosed in the reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There were no changes in our internal control over financial reporting (as defined in the Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the fiscal quarter ended March 31, 2021, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
31

Table of Contents
PART II. OTHER INFORMATION
Item 1.Legal Proceedings
As disclosed in Note 11 in the Notes to Condensed Consolidated Financial Statements included in this Quarterly Report, we are engaged in certain legal proceedings, and the disclosure set forth in Note 11 relating to legal proceedings is incorporated herein by reference.
Item 1A.Risk Factors
There have been no material changes to the risk factors disclosed in the 2020 Annual Report under Item 1A. “Risk Factors.”
Item 2.Unregistered Sales of Equity Securities and Use of Proceeds

Period |  | Total Number of Shares Purchased (1) |  | Average Price Paid Per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (1) |  | Maximum Number (or Approximate Dollar Value) of Shares That May Yet Be Purchased Under the Plan or Programs (1)
January 2021 |  | — |  |  | $ | — |  |  | — |  |  | — |
February 2021 |  | 43,473 |  |  | 6.81 |  |  | — |  |  | — |
March 2021 |  | 6,188 |  |  | 7.82 |  |  | — |  |  | — |
Total |  | 49,661 |  |  | $ | 6.94 |  |  | — |  |  | — |

_______________________________
(1)Shares were withheld to pay for tax obligations due upon the vesting of restricted stock held by certain employees granted under the NN, Inc. 2019 Omnibus Incentive Plan (the “Plan”). The Plan provides for the withholding of shares to satisfy tax obligations. It does not specify a maximum number of shares that can be withheld for this purpose. These shares may be deemed to be “issuer purchases” of shares that are required to be disclosed pursuant to this Item.
Item 3.Defaults Upon Senior Securities
None.
Item 4.Mine Safety Disclosures
Not applicable.
Item 5.Other Information
None.
32

Table of Contents
Item 6.Exhibits

Exhibit Number |  | Description
3.1 |  | Certificate of Designation of Series D Preferred Stock (incorporated by reference to Exhibit 3.1 to NN, Inc.’s Current Report on Form 8-K filed on March 22, 2021)
4.1 |  | Common Stock Warrant (incorporated by reference to Exhibit 4.1 to NN, Inc.’s Current Report on Form 8-K filed on March 22, 2021)
10.1 |  | Securities Purchase Agreement, dated March 22, 2021, by and between the Company and the Purchaser (incorporated by reference to Exhibit 10.1 to NN, Inc.’s Current Report on Form 8-K filed on March 22, 2021)
10.2 |  | Board Observer Agreement, dated March 22, 2021, by and between the Company and the Purchaser (incorporated by reference to Exhibit 10.2 to NN, Inc.’s Current Report on Form 8-K filed on March 22, 2021)
10.3 |  | Term Loan Credit Agreement, dated March 22, 2021, by and among the Company, as borrower, and Oaktree Fund Administration, LLC, as administrative agent (incorporated by reference to Exhibit 10.3 to NN, Inc.’s Current Report on Form 8-K filed on March 22, 2021)
10.4 |  | Credit Agreement, dated March 22, 2021, by and among the Company, as borrower, and JPMorgan Chase Bank, N.A., as administrative agent (incorporated by reference to Exhibit 10.4 to NN, Inc.’s Current Report on Form 8-K filed on March 22, 2021)
31.1 |  | Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended.
31.2 |  | Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as amended.
32.1 |  | Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2 |  | Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS |  | XBRL Instance Document
101.SCH |  | XBRL Taxonomy Extension Service
101.CAL |  | Taxonomy Calculation Linkbase
101.LAB |  | XBRL Taxonomy Label Linkbase
101.PRE |  | XBRL Presentation Linkbase Document
101.DEF |  | XBRL Definition Linkbase Document
104 |  | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

* Management contract or compensatory plan or arrangement

33

Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

| NN, Inc.
| (Registrant)
Date: May 7, 2021 | /s/ Warren A. Veltman
| Warren A. Veltman
| President, Chief Executive Officer and Director
| (Principal Executive Officer)
| (Duly Authorized Officer)
Date: May 7, 2021 | /s/ Thomas D. DeByle
| Thomas D. DeByle
| Senior Vice President—Chief Financial Officer
| (Principal Financial Officer)
| (Duly Authorized Officer)
Date: May 7, 2021 | /s/ Michael C. Felcher
| Michael C. Felcher
| Vice President—Chief Accounting Officer
| (Principal Accounting Officer)

34